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Structural knowledge of the metal environment is important in understanding the 
function of metalloproteins and is critical to harnessing their power. Modeling within a 
protein scaffold offers a pathway to the rational design of desired function s by use of 
Nature’s own tools; both to gain novel insights into metal-mediated processes and to create 
new processes. The broad goal of this work is successful engineering of monooxygenase 
function into model proteinic scaffolds. We seek to model within a prototype scaffold the 
function of the PHM (peptidylyglycine--hydroxylating monooxygenase) and DβM 
(dopamine -monooxygenase) family of enzymes, which are capable of remarkable C-H 
bond activation under ambient conditions with ascorbic acid and molecular oxygen. 
In Chapter 2, the power of the cavity mutant approach to small molecule processing 
in the azurin scaffold is demonstrated through description of the first reported Cu(II)-sulfenic 
acid species. This species, prepared in high yield through copper mediated reduction of 
hydrogen peroxide, represents the first reported chemical transformation in ‘converted’ 
electron transfer protein. Furthermore, it is the first report of a synthetic sulfenic acid 
functionality within the context of a protein. The latter is an important contribution to the 
field of protein design, as precise knowledge and control of cysteine oxidation state is an 
important parameter in dictating function in cysteine-containing native and designed peptides 
and proteins.  
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In Chapter 3, a series of Type-2 azurin variants is reported in which the anionic redox 
‘chameleon’ Cys-112 is replaced with neutral His-112 in an effort to develop a robust protein 
scaffold for modeling of substrate C-H bond activation.  A series of surrogate, intramolecular 
substrates that offer an accessible H-atom were generated through site directed mutagenesis 
at the axial Met-121 position above the trigonal plane.  The spectral characterization of the 
series is described, and mutant-dependent reactivity with added O2 and ascorbic acid is 
described.  
In Chapter 4, the fatty-acid carrier protein, Cellular Retinoic Acid Binding Protein 
(CRAPB-II) is described in the context of hosting small molecule catalysts.  Initial 
investigations into the design of a binding site for the carbene transfer catalyst, rhodium 
acetate, will be described, as well as investigation into the utility of the CRABP-II scaffold 
for aqueous nitric oxide sensing. 
Finally, in Chapter 5 will be discussed the development of a temperature independent 
pH buffer, along with demonstration of its utility in low-temperature antibiotic storage, and 
low temperature spectroscopy. 
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Chapter 1. Modeling oxygen activation within a cavity mutant of azurin 
 
1.1 Introduction 
 
1.1.1 Introduction to copper centers in biology 
 
Nature has exploited the copper ion for an incredible assortment of biological 
functions- including, but not limited to, signal transduction, oxygen transport and activation, 
and electron transfer.1 As an essential but potentially toxic nutrient, copper acquisition and 
distribution is mediated by a host of copper transporters and chaperones2 that deliver copper 
to discreet enzyme/protein active sites.3 Study of the copper-metalloenzyme structure-
function relationship has greatly advanced research in the fields of copper-related disease, 
bio-inspired energy production, and metabolism research.  
Copper centers have been identified in over 30 proteins14 in 7 motifs5 where they can 
be classified based on the number of copper ions per active unit, spectroscopic fingerprints, 
and the role the functional units play in nature. The simplest (and most chemically diverse) 
are the mononuclear copper sites. These have been classically divided into ‘Types’ based on 
the spectral parameters and ligand environment associated with the copper ion.6‐8 This 
classification has proven useful in the prediction of ligand geometries and reactivities in 
natural and designed copper proteins.9 Type-1 (T1) blue-copper proteins10 function as 
efficient electron transfer agents, and the active site consists of a single copper ion ligated in 
a distorted tetrahedral fashion by two histidine ligands, a cysteinate ligand, and a weakly 
bound axial ligand of various sorts. These T1 centers are characterized by a strong SCu 
LMCT band around 600 nm in the electronic absorption spectrum ( = 3000-6000 M-1cm-1) 
giving a solution of the complex a distinct blue color. A high degree of covalency between 
the copper ion and the cysteine sulfur atom also results in contracted gz values in the EPR 
spectra of these sites (50-60 G). Type-2 (T2) centers exhibit Az values of 150-175 MHz in 
their EPR spectra, and may or may not have strong SCu LMCT bands around 450 nm. 
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These sites also and have multiple biological functions including electron transfer (e.g., 
PHM- CuH site)11 and small molecule binding and processing (e.g., glucose oxidase and 
Cu/Zn-SOD).12  
The evolutionary relationship between the types of copper centers has been 
investigated through structural and genetic data mining.13 It has been shown that T1 copper 
proteins evolved from metal-free peptide components, while T2 centers copper centers have 
evolved from converted iron and manganese-containing sites.13  This remarkable convergent 
and divergent evolution of metal cofactor identity has been observed in other analogous 
cellular functions, (e.g. single electron transfer in the case of cupredoxins vs. rubredoxins or 
oxygen transport in the case of hemacyanins vs. myoglobins), owing at least in part to the 
accessibility of each metal to multiple stable oxidation states in aqueous solution. As 
described herein, the copper ion is also found to be essential in a powerful enzyme capable of 
substrate C-H bond activation using molecular oxygen. These enzymes, required 
ubiquitously for the production of norepinepherine and peptide hormones in higher 
eukaryotes,14 parallel in essence the function of the iron-based, cytochrome P-450 family.15  
 
1.1.2 Structure and function of PHM (Peptidylglycine--hydroxylating 
monooxygenase) and DM (Dopamine -monooxygenase) enzymes 
 
A particularly remarkable role of copper in biology is in the activation of molecular 
oxygen towards insertion into inert hydrocarbon bonds. For example, copper has been shown 
to facilitate post-translational oxidative modification of tyrosine with molecular oxygen to 
generate the topaquinone (2,4,5-trihydroxyphenylalanine) cofactor, essential for the catalytic 
function of copper amine oxidases.16 This reaction is unique in that self-processing occurs 
spontaneously with added copper in the presence of dissolved oxygen. The unique post-
translational cross-linking of active site cysteine and tyrosine residues in galactose oxidase 
has also been shown to require copper ion and was long thought to proceed along an O2 
mediated pathway,17, 18 although it has recently been shown that this transformation does not 
require the presence of O2 to proceed.19  
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Remarkably, two enzymes have been found capable of copper-based reduction of 
bound dioxygen towards hydroxylation of unactivated C-H bonds of a substrate. These 
enzymes- dopamine -monooxygenase (DM)- which catalyzes the synthesis of 
norepinepherine on the pathway to dopamine biosynthesis) and peptidylglycine -hydroxy 
monooxygenase (PHM)- which is responsible for the first step in the ubiquitous amidation of 
peptidic hormones- are thought to operate in a similar fashion based on structural and 
mechanistic studies (Figure 1.1).11, 20‐22 Both enzymes utilize dissolved dioxygen and reducing 
equivalents from ascorbic acid to affect hydroxylation of an unactivated C-H bond. 
 
 
Figure 1.1. Hydroxylation reaction catalyzed by DM and PHM enzymes are thought to proceed 
along the same chemical pathway (redrawn from ref. 23). 
 
Much progress has been made towards identification of a structure/function 
relationship in the copper-based reduction of dioxygen and hydroxylation in DM and 
PHM.11, 23 cDNA and peptide sequencing analysis20 suggested that PHM contained two metal 
binding sites and seven disulfide bonds. In 2004, the crystal structure of PHM was reported24 
and made a seminal contribution to understanding the role of the two copper centers in 
promoting hydroxylation of such an inert bond under ambient biological conditions. 
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Figure 1.2. Ribbon diagram of the crystal structure of PHM, showing the intersubunit cleft and two 
copper sites (PDB code: 1SDW ref. 24) 
 
The crystal structure analysis of PHM revealed a pseudodimer, with two similar but 
nonidentical subunits folded from one polypeptide (Figure 1.2). Also resolved were two 
uncoupled copper sites, separated by an 11 Å span between two clefts of folded protein 
structure (Figure 1.3).24 Remarkably, as the crystal was grown in the absence of the peptide 
substrate, bound dioxygen substrate was observed at the CuM site, giving structural support to 
the hypothesis that this was the site of oxygen reduction, while the other copper site (CuH) 
served a role in electron transfer. This and subsequent structural information, along with 
decades of mechanistic data, have resulted in a proposed scheme for the activation of 
dioxygen with the two non-coupled copper centers. 
 
 
Figure 1.3. Crystal structure of PHM copper sites, separated by an 11 Å span in the precatalytic 
complex (ref. 24) 
   
 
5 
 
 
 In a paradigmatic mechanism proposed in 2006 by Klinman and coworkers (Figure 
1.4),11 oxygen insertion into the unactivated C-H bond of bound substrate proceeds first with 
the binding of dioxygen to a reduced CuM site. The Cu(I) center at this site then reduces 
dioxygen to form a Cu(II)-superoxide complex, and this species performs a direct hydrogen 
atom abstraction from the bound substrate. After an electron transfer from the CuH site 
(consisting of a discreetly bound copper ion ligated to three histidine ligands), oxygen 
splitting, and radical rebound, the active site is regenerated, and a hydroxylated substrate 
leaves the active site pocket. 
 
 
Figure 1.4. Proposed superoxide mechanism for dioxygen activation and insertion into an enzyme-
bound substrate. (Figure borrowed from ref. 11) 
 
Although experimental25,  26 and computational27‐29 support exists for direct H-atom 
abstraction with a Cu(II)-superoxo complex, much debate exists over the actual oxidizing 
species responsible for abstracting the hydrogen atom,23 and a mechanism involving a Cu(II)-
OOH or higher valence Cu(III)O- (ie. {CuO}+2) species has not been definitively ruled out.23, 
30,  31 Though mechanistic studies with the native enzyme using techniques such as site 
directed mutagenesis and H/D isotopic effects11, 22 have clarified these questions, the transient 
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nature and high oxidizing power of these manifolds make their study difficult in a native 
system that is poised for turnover. In light of these limitations, much insight has been gained 
through modeling of the individual mononuclear copper sites and the active species using 
small molecules. 
 
1.1.3 Small molecule models for PHM copper sites 
 
 Much effort has been invested in the modeling of the individual copper sites of PHM, 
with the goal of duplicating and elucidating key structural features imparted on the copper 
ions that enable oxygen activation and substrate hydroxylation.23, 29, 32 Focus in the field has 
been centered on modeling of the unusual (and suspected dioxygen activating) CuM site, 
while comparatively less effort has been made towards modeling the more prototypical Type-
2 CuH site. 
  Using small-molecule ligand sets to mimic the enzyme copper sites offers access to 
an array of organic solvents, such as acetone and THF, and their associated low freezing 
points with respect to aqueous solution.33 Thus, species that are thermally unstable at room 
temperature may become isolable at low temperature. To date, several Cu(II)-superoxo and 
Cu(II)-hydroperoxo species have been prepared using this approach, (and some even 
crystallized) in an attempt to gain more insight into the mechanism of copper-based dioxygen 
activation (Figure 1.5). Successful ligand systems have thus far had in common: 1) 
exclusively N-donor ligands, and 2) significant steric protection of the unit consisting of the 
copper ion and reduced oxygen; in part to prevent dimerization to bridged (-peroxo)- or bis 
(-oxo)dicopper complexes.33 
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Figure 1.5. Small-molecule complexes of Cu(II)-superoxo and Cu(II)–hyodroperoxo complexes that 
mimic proposed oxidizing species in the CuM site.  
 
Models of Cu(II)-OO- complexes 
 
The first mononuclear Cu(II)-superoxo complex was reported in 2004 by Schindler 
and coworkers,34 and the crystal structure was solved in 2006.35 The complex (Figure 1.5.a) 
was prepared from addition of O2 to the Cu(I) form of the bulky TMG3tren ((tris(2-(N-tetra-
methylguanidyl)ethyl)amine ligand system. Upon warming, O2 was released with no 
oxidative damage to the ligand system, in analogy to the mechanism of biological oxygen 
storage proteins such as myoglobin and hemacyanin. Resonance Raman spectroscopy 
supported an end-on binding mode to the metal center.  
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Therafter, the Karlin group reported an end-on Cu(II)-superoxo complex (Figure 
1.5.b),36, 37 citing rational tuning of the ligand electronics (N-donor ability) to create a more 
stabile end-on Cu(II)-superoxo complex at low temperature (-80 C). In parallel to the 
TMG3tren complex, disproportionation into O2 and intact ligand is observed upon warming. 
In 2009, Itoh and coworkers reported a model Cu(II)-superoxo complex (Figure 1.5.c) 
capable of ligand degradation through hydroxylation upon warming without prior oxidation 
to the hydroperoxo complex.38 This report offered the first experimental validation that 
Cu(II)-superoxo complexes can perform hydroxylation chemistry. Interestingly, this ligand 
exhibited a 3-coordinate geometry around the copper ion, analogous to that of the CuM site of 
PHM and DM,24 suggesting that coordination mode and ligand geometry are important 
factors in dictating oxidizing power. 
  
Models of Cu(II)-OOH complexes 
 
The first mononuclear Cu(II)-hydroperoxo complex was reported in 1998, following 
successes by the Solomon Group in preparation of bimetallic copper hydroperoxo 
complexes.39 The first crystal structure of such a complex was reported by Tolman and 
coworkers (Figure 1.5.d),29 wherein the authors cited steric protection and hydrogen bonding 
interactions from designed amide groups as being critical for successful isolation and 
characterization of the thermally unstable Cu(II) hydroperoxo species. Crystal structure 
analysis confirmed an end-on coordination mode to the copper ion. The same year, another 
report of an end-on Cu(II) hydroperoxo complex using a bulky pyridinyl-based ligand system 
(Figure 1.5.e) was published, while the authors again quoted steric bulk and ligand hydrogen 
bonds for the stability of the generated hydroperoxo species.40  
 In 2008 the Karlin group, using Schindler’s TMG3tren-hosted Cu(II)-superoxo 
complex,35 showed capacity for H-atom abstraction of added phenolic substrates to form the 
corresponding Cu(II)-hydroperoxo complex (Figure 1.5.f) and ultimately the bio-relevant 
alkoxy complexes.37 Ligand C-H hydroxylation was observed upon warming, but only 
following addition of phenols to the superoxo complex. This pioneering report of ligand C-H 
hydroxylation strongly suggested that the Cu(II)-superoxo complex lacked oxidative capacity 
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in this chemistry (albeit in an intramolecular fashion), while the corresponding Cu(II)-
hydroperoxo complexes are the competent oxidizing agents in this system and perhaps in 
vivo. 
 
1.1.4 Azurin cavity mutants as copper-site scaffolds 
 
While small molecule model systems have made a strong contribution to the current 
understanding of the metal sites in these proteins, a parallel approach to investigation of 
active site features is in the redesign of the structural parameters into a model protein 
scaffold. This approach allows access to Nature’s toolbelt, including natural amino acid 
residues, a bulky proteinic context, and an aqueous environment, while still allowing for 
generous tunability using modern biochemical methods.9 
Azurin from Pseudomonas aeruginosa has been the seminally investigated T1 blue 
copper protein. The small (14 kDa) protein harbors a single, well characterized copper site, 
and plays a role in biological electron transfer through the redox active metal center. Both 
tolerance of the Greek-key -barrel fold to mutation and high expression levels of variants 
have helped establish the value of azurin as a general scaffold protein for the engineering of 
copper (and even non-copper)41 cofactors within a proteinic environment in water.9 Azurin 
has previously been used to model the copper site of rusticyanin,42 the CuA site of the 
cytochrome c oxidase complex,43 and the unique T2 copper site in nitrosocyanin (Lu, 
unpublished). In a recent and most salient example, a second copper-binding site was 
introduced into the azurin scaffold through site-directed mutagenesis, successfully modeling 
the presence of two non-coupled copper sites in the same protein scaffold.44 Armed with 
these successes, we sought to expand the modeling capacity of the azurin scaffold to 
accommodate small molecule docking and activation. 
While the coordinative saturation of copper observe in wild type azurin can protect 
and facilitate single-electron redox events, oxygen-processing metalloenzymes necessarily 
require access to a conformation with an open-binding site. Examples of man-made 
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mutations of the azurin scaffold to produce coordinatively unsaturated copper centers have 
been reported; however no reports to date accomplish this in the context of small molecule 
activation. In one example, the equatorial ligand His-117 was mutated to a small Gly 
residue,45, 46 and subsequent treatment with exogenous ligands regenerated Type-1 features as 
well as Type-2 features through ‘cavity complementarity’.9,  47 In a second example, axial 
ligand Met-121 was mutated to Gly and Ala, allowing for the docking of small molecules 
including SCN-, CN-, and N3- to produce ‘new’ Type-1 copper proteins.48‐52 As stated above, 
these reports established strategies for small molecule access to the copper center in azurin, 
but did not address metal-based chemical processing of the docked molecule. We decided to 
first investigate an established cavity mutant for oxidant processing capabilities. 
 
1.1.5 Crystal structure of Cu(II)-M121G azurin shows relief of coordinative 
saturation 
 
As the Met-121 to Gly mutant of azurin has been shown to retain Type-1 
characteristics, suggesting minimal structural perturbation, it was chosen for initial 
investigation into the cavity-assisted small molecule processing. Crystals of Cu(II)-loaded 
M121G azurin suitable for X-ray analysis were obtained via hanging-drop vapor diffusion, 
and the structure was determined at 1.98 Å resolution. Shown in Figure 1.6 are ribbon 
diagrams outlining the protein fold in the crystal structures of wild-type and M121G azurin. 
It can be seen that the Greek-key -barrel motif of azurin is retained in the M121G variant, 
and only sparsely is loop and sheet secondary structure lost with the M121G mutation. It was 
noted that the section of loop containing native Met-121 moves slightly closer to the active 
site in the M121G variant, perhaps the result of slight collapse due to the removal of steric 
bulk from that region. 
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Figure 1.6. Ribbon diagrams showing the crystal structure of oxidized forms of wild-type azurin (left) 
(PDB code: 4AZU)53 and M121G azurin (right). 
 
Analysis of the copper site of the M121G variant revealed that the geometry around the 
copper ion was quite similar to that of wild type azurin (Figure 1.7). An equatorial plane was in each 
case established by two His ligands and one Cys ligand, while a crystallographically conserved water 
molecule was found 2.99 Å from the copper ion, occupying the native Met-121 axial ligand position. 
This M121G crystal structure confirmed previous reports, which suggested the presence of an axial 
water based on resonance Raman spectroscopy.52 Although slight deviations in bond lengths to the 
copper ion were observed (Table 1.1), the overall geometry was quite similar between the two 
variants. A ‘short’ Cu-S bond length of 1.96 Å in the M121G mutant further supported the retention 
of true Type-1 character, corroborating initial spectroscopic investigations.49 Interestingly, analysis of 
the crystal structure of the M121A azurin variant showed no crystallographic water in the position 
axial to the copper ion,51 suggesting that, in azurin, the subtle difference in size between axial Ala 
versus Gly dictates water access to the metal center, in both solution and solid phase.  
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Figure 1.7. Active site geometry of (left) wild type (PDB code: 4AZU)53 and (right) M121G azurin 
revealed by crystal structure analysis. 
 
Table 1.1. Copper-ligand bond distances (Å) in Wild Type and M121G azurin crystal structures 
Protein  Wild Type M121G
Cys112(S)‐Cu 2.27 1.96
His117(N)‐Cu  2.11 1.95
His 46(N)‐Cu  1.99 1.95
Gly45(O)‐Cu  2.84 2.93
Met121(S)‐Cu 3.18 ‐
H2O(O)‐Cu  ‐ 2.99
 
A surface accessibility map was generated using VMD software,54 using atom-coordinates 
obtained from the crystal structures of M121G and wild type azurin. The surface contour of the 
protein was mapped with a probe sphere radius of 65 pm to simulate O-atom accessibility. As can be 
seen in Figure 1.8, a clear cavity in the wall of the protein is generated from replacement of the Met-
121 residue with the small and flexible glycine residue. We reasoned that this channel allows for the 
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observed water access to the copper center, as the protein was metallated in the folded state. These 
results provided, for the first time, structural evidence for the capacity to accommodate of small 
molecule ligands in the M121G scaffold.  
 
Figure 1.8. Surface accessibility maps, generated in VMD from crystal structure data using a) wild-
type and b) M121G azurin show a channel leading from the solvent to the active site copper ion. 
Surfaces were generated using an O-atom radius of 65 pm. 
 
1.2 Experimental 
 
1.2.1 DNA mutagenesis, transformation, and plasmid isolation 
 
Site directed mutagenesis was performed using primers designed in a 24-base, 8-codon 
scheme (X-X-X-M-X-X-X); where X is a perfect match codon to the template, and M is the 
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codon to be exchanged. PCR reactions were performed on a Biorad C1000 Thermal Cycler 
with 48/48 Dual Fast Reaction Module using solutions containing: 40 L sterile Millipore 
water; 5 L 10x reaction buffer, 1 L forward primer (1 ng/L), 1 L reverse primer (1 
ng/L), 1 L template DNA (1 ng/L), 1 L dNTP’s (10 mM, PROMEGA) and 1 L Pfu 
Turbo polymerase (Stratagene). Product solutions were treated with restriction enzyme dpn-1 
(0.5 L/ 1U) for 4 hours at 37 C to remove methylated DNA template from the solution. 
The resulting solutions were transformed (2 L) into 50 L competent XL10 GOLD 
(Stratagen, La Jolla, CA) cells for amplification and sequencing analysis.  
In a typical transformation, 2 L of PCR reaction solution was added to 50 L 
competent cells in a Falcon tube at 4 C on ice and allowed to stand for 30 mins. The 
solution was then exposed to 42 C for exactly 30 seconds, followed by a fast return to 4 C 
by plunging into ice for 2 mins. To the solution was added 300 L sterile SOC media, and 
the solution was allowed to shake at 37 C for 45 minutes. An aliquot of the resulting 
solution (80 L) was spread on an LB plate containing kanamycin (100 mg/L) and the plate 
was allowed to incubate for 18 hours. 
A 5 mL sterile LB media broth was treated with kanamycin to 100 mg/L, and 
inoculated with a single colony from the 18 hour plate. The solution was allowed to 
proliferate with shaking at 37 C for 18 hours, and the cells collected via centrifugation at 
4500 r.c.f. for 10 minutes. The plasmid DNA was purified using a Qiagen plasmid DNA 
purification kit (Valencia, CA) according to the instructions provided by the manufacturer. 
Successful mutagenesis was confirmed via DNA sequencing analysis using a T-7 promotor, 
and was performed at the Biotechnology Center at University of Illinois at Urbana-
Champaign. 
 
1.2.2 Transformation into BLR vector for protein expression 
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For protein expression, 5 L desired miniprepped plasmid DNA (1 ngL) was 
transformed into BL-21* cells (Stratagen) according to the above method. Single colonies 
grown on kanamycin treated LB plates were used to inoculate 5 mL sterile LB broth. The 
solution was shaken at 37 C for 8 hours, after which one milliliter was used to prepare a cell 
stock (if this was the first time working with the mutant). The remaining four milliliters were 
used in the protein expression. 
 
1.2.3 Protein expression and purification 
 
Azurin was expressed and purified according to a slightly modified version of a 
previously reported procedure.48,  49 To four, 2 L volumes of sterile 2xYT media at 25 C 
containing 150 mg/L kanamycin was added 1mL each of cells from step 1.2.2, and the 
solutions shaken at 210 rpm at 25 C for 15 hours. To each solution was added 50 mg/L 
IPTG to induce protein expression. After shaking for 5 more hours, the cells were collected 
via centrifugation at 8000 rpm for 10 mins. The cell pellets, divided into 6 portions for 
centrifugation, were each treated with 150 mL 20% sucrose solution, containing 100 mM 
TrisHCl and 1 mM EDTA, pH 8.0, and shaken vigorously at room temperature for 60 
minutes. The cells were again collected via centrifugation, and each portion was treated with 
150 mL of a solution containing 4 mM NaCl and 1 mM DTT, and shaken vigorously for 20 
minutes. The cells were again centrifuged for 10 minutes, and the supernatant was collected 
in a sterile 1 L flask. This solution was treated slowly with 1/10 volume of 500 mM sodium 
acetate solution, pH 4.1 while stirring. After stirring 10 minutes, the solutions were again 
centrifuged, and the supernatant was collected into a sterile 1 L flask. To this flask was added 
SP-sepharose (Fast Flow) media, pre-equilibrated in 50 mM ammonium acetate, pH 4.1. 
After the protein adsorbed to the media, the media was collected by decantation, loaded onto 
a column, and the protein eluted with an increasing pH gradient from 4.1 to 6.4. The protein 
eluded with 85% pH 6.4 buffer, and fractions containing protein (Amax 280 nm) were 
collected and concentrated to ~10-20 mL using an Amicon Untrafiltration device with a 
membrane cutoff of 10,000 MWCO. This solution was further purified via ion exchange 
   
 
16 
 
chromatography by passing it through a Hi-Trap column containing Sepharose Q-HP media 
(GE Healthcare), at 4 mL/min, as the protein was not retained with an elution buffer of 
ammonium acetate, pH 6.4, while contaminants bound to the column. Purity was assessed 
with SDS-PAGE and electrospray mass spectrometry. 
 
1.2.4 Metallation and desalting 
 
Metallation reactions for azurins were performed in 50 mM ammonium acetate 
buffer, pH 6.4. In a typical preparation, 10-15 mL of 0.5 to 1.0 mM protein was treated 
slowly with 3 equivalents CuSO4 solution (from a 50 mM stock) and allowed to stir for 20 
minutes. The solution was then concentrated to 1-2 mL using an Untracentricon membrane 
(Millipore, 10,000 MWCO) and added to a PD-10 column equilibrated with 50 mM 
ammonium acetate, pH 6.4. Fractions of protein were collected in 0.5 mL aliquots and were 
quantified via UV-vis spectroscopy. To prepare CuI-proteins, the CuII-protein was first 
prepared, degassed, and brought into an anaerobic glovebox. To a stirred solution of protein 
(1-2 mL of 2 mM) was slowly added small amounts of a sodium ascorbate/TMPD (125 
mg/25 mg) blend until the solution became colorless. The solution was then passed down a 
PD-10 column, and colorless 0.5 mL fractions were collected in numbered tubes. Small 
aliquots (25 L) of each solution were removed from the glovebox for quantification via UV- 
vis (280nm ~ 9800 M-1cm-1).55 
 
1.2.5 Degassing and anaerobic procedures 
 
For anaerobic work, aqueous solutions were first prepared and then degassed using 
standard Schlenk technique, with the exception of sodium ascorbate/TMPD blend, which was 
degassed and distributed as a powder. To degas, stirred solutions on ice were exposed to 
vacuum (5-10 torr) for 20 minutes, followed by a nitrogen purge for 10 minutes, and this 
procedure was repeated three times. The majority of the anerobic work was performed in an 
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MBraun glovebox. All plastics were subjected to a 48 hour vacuum treatment in addition to 
the normal cycle before entering the glovebox. Size exclusion media (Sephadex G-25, GE 
Healthcare) suspended in Millipore water was first degassed, and PD-10 columns were 
assembled in the glovebox using emptied shells and filters. This technique ensured complete 
removal of dissolved O2 from the size exclusion apparatus. Protein concentrations were 
determined by obtaining the UV-vis spectrum of small aliquots removed from the glovebox. 
Anaerobic UV-vis experiments were performed in Thumberg cells equipped with a rubber 
stopper and argon inlet for blanketing during reactions. 
  
1.2.6 Crystallography 
 
Crystals of Cu(II)-M121G azurin suitable for X-ray diffraction grew over two weeks 
at 4 C using the hanging drop method, which consisted of suspension of a 2 L droplet of 
protein (1.5 mM) plus 2 L droplet buffer (15% PEG 2000 containing 250 mM CaCl2, 250 
mM LiNO3, and 80 mM NaOAc, pH 6.0) above 250 L well buffer (15% PEG 2000 
containing 250 mM CaCl2, 250 mM LiNO3, and 80 mM NaOAc, pH 6.0). Crystal conditions 
for M121G azurin and other crystal targets were varied systematically with such variables as 
PEG molecular weight, protein concentration, pH, and buffer contents until suitable crystals 
were observed under a microscope. 
 
1.2.7 Computer modeling and EPR simulations 
 
Computer modeling and simulations were performed using VMD software.54 Energy 
minimizations and molecular dynamics were performed using a CHARM32 forcefield and 
NAMD scalable molecular dynamics software package.56 The coppper(II) ion was simulated 
using stored electrostatic parameters for the zinc(II) ion. In a typical energy minimization and 
molecular dynamics treatment, a model was subject to 2000 and 10000 cycles respectively at 
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1 fsec/cycle. EPR simulations were performed by Dr. Mark Nilges in the EPR center at the 
University of Illinois using SIMPOW6 software.57, 58 
 
1.3 Project Goals 
 
Structural knowledge of the metal environment is important in understanding the 
function of metalloproteins and is critical to harnessing their power. Modeling within a 
protein scaffold offers a pathway to rational design of desired function using Nature’s 
toolbelt; to both gain key insights into metal-mediated processes, and demonstrate true 
understanding through re-creation.  
In Chapter 2, the power of the cavity mutant approach to small molecule processing 
in the azurin scaffold is demonstrated through description of the first reported Cu(II)-sulfenic 
acid species. This species, prepared in high yield through copper mediated reduction of 
hydrogen peroxide, represents the first report of small molecule processing with a 
‘converted’ electron transfer protein. Furthermore, it is the first report of a synthetic sulfenic 
acid functionality within the context of a protein. The latter is an important contribution to 
the field of protein design, as precise knowledge and control of cysteine oxidation state is an 
important parameter in dictating function in cysteine-containing native and designed peptides 
and proteins. In Chapter 3, a series of Type-2 azurin variants is reported in which the anionic 
redox ‘chameleon’ Cys-112 is replaced with neutral His, in an effort to develop a robust 
proteinic scaffold for modeling of substrate C-H bond activation. A series of surrogate, 
intramolecular substrates, offering an accessible H-atom, were generated through site 
directed mutagenesis at the axial Met-121 position above the trigonal plane. The spectral 
characterization of the series is described, and mutant-dependent reactivity with added O2 
and ascorbic acid is discussed. In Chapter 4, the fatty-acid carrier protein CRAPB-II is 
described in the context of hosting small molecule catalysts. Initial investigations into the 
design of a binding site for the carbene transfer catalyst, rhodium acetate, will be described; 
as well as investigation into the utility of the CRABP-II scaffold for aqueous nitric oxide 
sensing. 
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In Chapter 5 will be discussed the development of a temperature independent pH 
buffer, along with demonstration of its utility in low-temperature antibiotic storage, and low 
temperature spectroscopy. 
 
1.4 References 
  
(1) Culotta, V. J. Biol. Inorg. Chem. 2010, 15, 1-2.  
(2) Robinson, N. J.; Winge, D. R. Annu. Rev. Biochem. 2010, 79, 537-562.  
(3) Cuillel, M. J. Incl. Phenom. Macro. 2009, 65, 165-170.  
(4) Lu, Y. In Electron transfer: Cupredoxins; Que, L., Jr, Tolman, W. B., Eds.; 
Biocoordination Chemistry; Elsevier: Oxford, UK, 2004; Vol. 8, pp 9.  
(5) Koval, I. A.; Gamez, P.; Belle, C.; Selmeczi, K.; Reedijk, J. Chem. Soc. Rev. 2006, 35, 
814-840.  
(6) Malkin, R.; Malmström, B. G. Advan. Enzymol. Relat. Areas Mol. Biol. 1970, 33, 177-
244.  
(7) Fee, J. A. Struct. Bond. 1975, 23, 1-60.  
(8) Lowery, M. D.; Solomon, E. I. Inorg. Chim. Acta 1992, 198-200, 233-243.  
(9) Lu, Y.; Yeung, N.; Sieracki, N.; Marshall, N. M. Nature 2009, 460, 855-862.  
(10) Solomon, E. I.; Penfield, K. W.; Gewirth, A. A.; Lowery, M. D.; Shadle, S. E.; Guckert, 
J. A.; LaCroix, L. B. Inorg. Chim. Acta 1996, 243, 67-78.  
(11) Klinman, J. P. J. Biol. Chem. 2006, 281, 3013-3016.  
(12) St. Clair, C. S.; Gray, H. B.; Valentine, J. S. Inorg. Chem. 1992, 31, 925-927.  
(13) Abolmaali, B.; Taylor, H.; Weser, U. Bioinorg. Chem. 1998, 91-190.  
(14) Eipper, B. A.; Stoffers, D. A.; Mains, R. E. Annu. Rev. Neurosci. 1992, 15, 57-85.  
(15) Ortiz, d. M. Chem. Rev. 2010, 110, 932-948.  
(16) Klinman, J. P.; Mu, D. Annu. Rev. Biochem. 1994, 63, 299-344.  
   
 
20 
 
(17) Firbank, S. J.; Rogers, M. S.; Wilmot, C. M.; Dooley, D. M.; Halcrow, M. A.; Knowles, 
P. F.; McPherson, M. J.; Phillips, S. E. V. Proc. Natl. Acad. Sci. U. S. A. 2001, 98, 
12932-12937.  
(18) Xie, L.; van, d. D. Proc. Natl. Acad. Sci. U. S. A. 2001, 98, 12863-12865.  
(19) Rogers, M. S.; Hurtado-Guerrero, R.; Firbank, S. J.; Halcrow, M. A.; Dooley, D. M.; 
Phillips, S. E. V.; Knowles, P. F.; McPherson, M. J. Biochemistry (N. Y. ) 2008, 47, 
10428-10439.  
(20) Taljanidisz, J.; Stewart, L.; Smith, A. J.; Klinman, J. P. Biochemistry (N. Y. ) 1989, 28, 
10054-10061.  
(21) Kolhekar, A. S.; Keutmann, H. T.; Mains, R. E.; Quon, A. S. W.; Eipper, B. A. 
Biochemistry (N. Y. ) 1997, 36, 10901-10909.  
(22) Takahashi, K.; Satani, M.; Gao, Y.; Noguchi, M. Int. Congr. Ser. 2002, 1233, 235-240.  
(23) Rolff, M.; Tuczek, F. Angew. Chem. , Int. Ed. 2008, 47, 2344-2347.  
(24) Prigge, S. T.; Eipper, B. A.; Mains, R. E.; Amzel, L. M. Science 2004, 304, 864-867.  
(25) Evans, J. P.; Ahn, K.; Klinman, J. P. J. Biol. Chem. 2003, 278, 49691-49698.  
(26) Bauman, A. T.; Yukl, E. T.; Alkevich, K.; McCormack, A. L.; Blackburn, N. J. J. Biol. 
Chem. 2006, 281:, 4190-4198.  
(27) Chen, P.; Fujisawa, K.; Solomon, E. I. J. Am. Chem. Soc. 2000, 122, 10177-10193.  
(28) Chen, P.; Solomon, E. I. Proc. Natl. Acad. Sci. U. S. A. 2004, 101, 13105-13110.  
(29) Gherman, B.; Heppner, D.; Tolman, W.; Cramer, C. J. Biol. Inorg. Chem. 2006, 11, 
197-205.  
(30) Kamachi, T.; Kihara, N.; Shiota, Y.; Yoshizawa, K. Inorg. Chem. 2005, 44, 4226-4236.  
(31) Crespo, A.; Marti, M. A.; Roitberg, A. E.; Amzel, L. M.; Estrin, D. A. J. Am. Chem. 
Soc. 2006, 128, 12817-12828.  
(32) Kuebel-Pollak, A.; Rüttimann, S.; Dunn, N.; Melich, X.; Williams, A. F.; Bernardinelli, 
G. Helv. Chim. Acta 2006, 89, 841-853.  
(33) Cramer, C. J.; Tolman, W. B. Acc. Chem. Res. 2007, 40, 601-608.  
(34) Schatz, M.; Raab, V.; Foxon, S. P.; Brehm, G.; Schneider, S.; Reiher, M.; Holthausen, 
M. C.; Sundermeyer, J.; Schindler, S. Ang. Chem., Int. Ed 2004, 43, 4360-4363.  
   
 
21 
 
(35) Würtele, C.; Gaoutchenova, E.; Harms, K.; Holthausen, M. C.; Sundermeyer, J.; 
Schindler, S. Angew. Chem., Int. Ed. 2006, 45, 3867-3869.  
(36) Maiti, D.; Lucas, H. R.; Sarjeant, A. A. N.; Karlin, K. D. J. Am. Chem. Soc. 2007, 129, 
6998-6999.  
(37) Maiti, D.; Lee, D.; Gaoutchenova, K.; Würtele, C.; Holthausen, M. C.; Sarjeant, A. A. 
N.; Sundermeyer, J.; Schindler, S.; Karlin, K. D. Angew. Chem., Int. Ed. 2008, 47, 82-
85.  
(38) Kunishita, A.; Kubo, M.; Sugimoto, H.; Ogura, T.; Sato, K.; Takui, T.; Itoh, S. J. Am. 
Chem. Soc. 2009, 131, 2788-2789.  
(39) Wada, A.; Harata, M.; Hasegawa, K.; Jitsukawa, K.; Masuda, H.; Mukai, M.; Kitagawa, 
T.; Einaga, H. Angew. Chem., Int. Ed. 1998, 37, 798-799.  
(40) Cheruzel, L. E.; Cecil, M. R.; Edison, S. E.; Mashuta, M. S.; Baldwin, M. J.; Buchanan, 
R. M. Inorg. Chem. 2006, 45, 3191-3202.  
(41) Hwang, H. J.; Carey, J. R.; Brower, E. T.; Gengenbach, A. J.; Abramite, J. A.; Lu, Y. J. 
Am. Chem. Soc. 2005, 127, 15356-15357.  
(42) Marshall, N. M.; Garner, D. K.; Wilson, T. D.; Gao, Y.; Robinson, H.; Nilges, M. J.; 
Lu, Y. Nature 2009, 462, 113-116.  
(43) Hay, M.; Richards, J. H.; Lu, Y. Proc. Natl. Acad. Sci. U. S. A. 1996, 93, 461-464.  
(44) Berry, S.; Mayers, J.; Zehm, N. J. Biol. Inorg. Chem. 2009, 14, 143-149.  
(45) van Pouderoyen, G.; Andrew, C. R.; Loehr, T. M.; Sanders-Loehr, J.; Mazumdar, S.; 
Hill, H. A.; Canters, G. W. Biochemistry (N. Y. ) 1996, 35, 1397-1407.  
(46) Hammann, C.; van Pouderoyen, G.; Nar, H.; Rüth, F. G.; Messerschmidt, A.; Huber, R.; 
den Blaauwen, T.; Canters, G. W. J. Mol. Biol. 1997, 266, 357-365.  
(47) den Blaauwen, T.; Hoitink, C. W. G.; Canters, G. W.; Han, J.; Loehr, T. M.; Sanders-
Loehr, J. Biochemistry (N. Y. ) 1993, 32, 12455-12464.  
(48) Chang, T. K.; Iverson, S. A.; Rodrigues, C. G.; Kiser, C. N.; Lew, A. Y. C.; Germanas, 
J. P.; Richards, J. H. Proc. Natl. Acad. Sci. U. S. A. 1991, 88, 1325-1329.  
(49) Di Bilio, A. J.; Chang, T. K.; Malmström, B. G.; Gray, H. B.; Karlsson, B. G.; Nordling, 
M.; Pascher, T.; Lundberg, L. G. Inorg. Chim. Acta 1992, 198-200, 145-148.  
(50) Vidakovic, M.; Germanas, J. P. Angew. Chem., Int. Ed. 1995, 34, 1622-1624.  
   
 
22 
 
(51) Tsai, L.; Bonander, N.; Harata, K.; Karlsson, G.; Vannga, T. Acta Crystallogr. D Biol. 
Crystallogr. 1996, 52, 950-958.  
(52) Fraczkiewicz, G.; Bonander, N.; Czernuszewicz, R. S. J. Raman Spectrosc. 1998, 29, 
983-995.  
(53) Nar, H.; Messerschmidt, A.; Huber, R.; van de Kamp, M.; Canters, G. W. J. Mol. Biol. 
1991, 221, 765-772.  
(54) Humphrey, W.; Dalke, A.; Schulten, K. J. Mol. Graph. 1996, 14, 33-38.  
(55) Den Blaauwen, T.; Van, d. K.; Canters, G. W. J. Am. Chem. Soc. 1991, 113, 5050-5052.  
(56) Phillips, J. C.; Braun, R.; Wang, W.; Gumbart, J.; Tajkhorshid, E.; Villa, E.; Chipot, C.; 
Skeel, R. D.; Kalé, L.; Schulten, K. J. Comput. Chem. 2005, 26, 1781-1802.  
(57) Nilges, M. J. Ph.D. Thesis, University of Illinois 1979. 
(58) Chang, H. R.; Diril, H.; Nilges, M. J.; Zhang, X.; Potenza, J. A.; Schugar, H. J.; 
Hendrickson, D. N.; Isied, S. S. J. Am. Chem. Soc. 1988, 110, 625-627.  
 
  
 
 
 
Cha
mod
 
2.1 
 
 
natur
of str
has b
enzym
Anion
metal
coord
thiol’
prote
desig
Figure
pter 2. Id
ification i
Introdu
2.1.1   Su
Post-trans
e to diversif
uctural and 
een shown
e/protein r
ic forms of
loproteins i
ination sph
s oxidation 
ins’ function
ned, cystein
 2.1. Biorele
entificatio
n M121G
ction 
lfenic acids 
lational oxi
y the residu
redox active
 to facilitat
egulation,8, 
 oxidized cy
ncluding nit
ere of other
state in the 
, and can o
e-containing
levent redox 
n and re
 azurin 
in biology 
dation of t
e towards a 
 disulfide bo
e a wide v
9 redox sig
steine are e
rile hydrata
s, such as z
active site o
ffer a furthe
 proteins.18
states of cyst
 
activity o
he cysteine 
myriad of ce
nds, further
ariety of p
naling,2,  10‐12
ssential liga
ses5 and thi
inc-containi
f designed p
r dimension
eine (Figure 
f a uniqu
thiol sidec
llular funct
 oxidation o
rocesses3,  4
  and gene
nds in the co
ocyanate hy
ng matrix m
roteins is a
 of control 
borrowed fro
e copper
hain has be
ions.1‐3 Beyo
f the sulfur 
including 
 regulation 
ordination 
drolases,7 a
etalloprotea
n important 
to the meta
m ref.19). 
-sulfenic 
en exploite
nd the form
atom of cys
metal bindi
(Figure 2.1
sphere of se
nd in the se
ses.8,  17 Cys
parameter i
l-binding sit
 
23 
acid 
d by 
ation 
teine 
ng,5‐7 
).13‐16  
veral 
cond 
teine 
n the 
es of 
   
 
24 
 
 
With the exception of the unique sulfinic-acid-reducing peroxiredoxin system,20 
sulfenic acids are the only oxidized sulfur constructs that can be reversibly reduced to 
disulfides and thiols in biological medium.  Nature has exploited this chemical reversibility 
to sense oxidants, store electrons, and switch enzyme conformations. Study of the sulfenic 
acid motif in aqueous proteinic systems has proven particularly challenging due to their rapid 
tendency to further oxidize to sulfinic and sulfonic acids, and their rapid reaction with 
available thiols to form disulfide bonds.21,  22 The development of selective reducing and 
labeling agents such as arsenite and dimedone,23 as well as the development of a sulfenic-
acid-specific antibody capable even of proteome mining for sulfenic acid content has 
significantly advanced this field.24,  25 Once thought of as transient intermediates, several 
examples of isolated sulfenic acids have been reported, the first nearly 100 years ago.26  
 
2.1.2 Metal-coordinated sulfenic-acid complexes 
 
Metal coordination is an established method of stabilizing formed sulfenic acids,21, 27‐
30 and it has been mentioned that this metal-hosting can provide insight into the nature of the 
sulfenic acid moiety.31 Figure 2.1 shows several pioneering examples of metal-coordinated 
sulfenic acids groups. The first metal-coordinated sulfenate group was rationally synthesized 
by oxidizing bidentate, thiol-containing, ethylene diamine analogs of the general structure 
(en)2Co(III)(-SCH2CH2NH2) or the coordinated cysteine variant (Figure 2.2.A). Other 
examples include the instructive report of the systematic oxidation of a thiol-coordinated 
nickel complex (Figure 2.2.B),32 as well as the report of the first O-bonded sulfenate complex 
using a 2-pyridine-sulfenato ligand (Figure 2.2.C). The latter example demonstrated the 
sulfenato ligand capacity to display different coordination modes, analogous to those 
established for sulfinato ligands.33 More recently, ruthenium arene complexes of the general 
type in Figure 2.2.D have allowed the electronic properties of the coordinated sulfenato 
group to be systematically tuned.34, 35 
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Figure 2.2. Lewis structures of representative metal-coordinated sulfenic acid species. 
 
2.1.3 Coordinated sulfenic acids in biology 
 
Oxidized cysteine ligands are found in a variety of metalloprotein/enzyme active 
sites.3 Remarkably, Nature has even evolved coordinated sulfenic acids - the least stable of 
the oxo-containing cysteinyl oxidization states - in a required proteinic context. In an elegant 
example, nitrile hydratase, a metalloenzyme which has long found utility in the industrial 
synthesis of acrylamide,36 exhibits a post-translationally-modified cysteine sulfenate and a 
cysteine sulfinate in the active site, both coordinated to the metal center (Fe or Co) (Figure 
2.3.A). In a similar evolutionary context is the thiocyanate hydrolase,7 which uses a similar 
coordination environment to decompose thiocyanate to carbonyl sulfide, ammonia, and 
water. In both enzymes, the sulfenic and sulfinic groups are unambiguously required for 
activity.5,  7 It is commonly postulated that such oxidized forms of cysteine in a metal site 
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encourage and stabilize the more oxidized form of redox-active metals, suppressing their 
potential toxicity in enzymes that do not require the metal center to participate in electron-
transfer.37,  38 In a more recent example, an iron-coordinated sulfenato coordination was 
observed when a thiolate-containing substrate analog in isopenicillin N-synthase was 
unexpectedly oxidized to a coordinated sulfenato group in crystallo (Figure 2.3.B); a 
connection to the biogenesis of nitrile hydratases and thiocyanate hydrolases was drawn.39 
 
 
 
Figure 2.3. VMD representation of crystal structures of A) nitrile hydratase40 (PDB code: 3A8O) and 
B) isopenicillin N-synthase39 (PDB code: 2VBB), showing metal-coordinated sulfenate groups. 
 
In summary, anaerobic treatment of reduced M121G azurin with hydrogen peroxide 
resulted in modification of the metal-coordinating Cys-112 thiolate to a sulfenic acid. The 
modification was detected via dimedone capture upon anaerobic unfolding of the protein.  
Exposure to air resulted in decomposition to a product containing a sulfonic acid (-SO3H) 
with little production of sulfinic acid (-SO2H), as evidenced by labeling experiments with 
enriched oxidant (H218O2). Spectral analysis may suggest both O- and S-atom coordination to 
the copper ion. 
It is clear that cysteine and cysteinate oxidation can diversify proteins towards a 
myriad of cellular functions, and control of the cysteine oxidation state in designed small 
molecules and proteins offers a new dimension of control over reactivity. We have shown 
success in generating the first copper-coordinated sulfenic acid complex to date. 
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Furthermore, it is the first report of an engineered sulfenic acid group in a protein scaffold.  
This modeling feat makes a large contribution to the understanding and manipulation of the 
redox state of the cysteinyl residue in the context of designed proteins, a power nature has 
long exploited towards critical biological functions. 
 
2.2 Experimental  
 
2.2.1 Site-directed mutagenesis  
 
The M121G azurin plasmid was prepared by Dr. Jun-Long Zhang in the Lu Group at 
the University of Illinois. Site-directed mutagenesis and plasmid transformation were 
performed on the wild-type azurin template plasmid (pet9a) using the Quick-change 
mutagenesis procedure (Chapter 1) with the forward primer 5’-CAC-TCC-GCA-CTG-GGG-
AAA-GGT-ACC-3’ and the corresponding complementary backward primer. DNA 
sequencing of the resultant plasmid was performed at the University of Illinois DNA 
Sequencing Center. The protein was expressed in BL-21* E.coli (Novagen, Madison, WI) 
and purified as reported in Chapter 1. Electrospray mass spectrometry confirmed the identity 
of the isolated variant. 
 
2.2.2 Spectroscopic measurements 
 
UV-vis absorption spectra were obtained at 20C on an HP Agilent 8453 diode array 
spectrometer. An extinction coefficient of 9800 M-1cm-1 at 280 nm was used to determine 
the protein concentration.  X-band EPR measurements were collected at 30 K on a Varian-
122 spectrometer equipped with an Air Products Helitran cryostat and temperature controller, 
with a collection frequency of 9.044 GHz and 100 kHz field modulation. EPR spectra were 
recorded in 25% glycerol as a glassing agent. All UV-vis spectra were recorded in 50 mM 
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ammonium acetate, pH 5.1 unless otherwise noted. EPR spectra were simulated with the 
automated fitting program, SIMPOW641,  42 and a program developed at the University of 
Illinois based on POW and MPOW software.  
 
2.2.3 Resonance Raman  spectroscopy 
 
Resonance Raman spectra were acquired by Julia Woertink through collaboration 
with the Solomon Group at Stanford University.  Spectra were collected at 77 K on a 
Princeton Instruments ST-135 back-illuminated CCD detector and a Specs 1877 CP triple 
monochromator with 1,200, 1,800, and 2,400 grooves per millimeter of holographic 
spectrograph gratings. Excitation was provided by a Coherent I90C-K Kr+ ion laser or an 
Innova Sabre 25/7 Ar+ CW ion laser. The spectral resolution was < 2 cm-1. 
Spectra were collected upon laser irradiation at 458 nm and 647 nm. Samples were 
first prepared in the Lu Laboratory and flash frozen in liquid N2 before being transported in a 
dry shipper to Solomon Laboratory.  Samples reported herein contained no cryoprotectant, as 
previously acquired sample spectra contained glycerol/ice vibrations in the region of interest. 
As a result, all samples herein required careful freezing over a 30-second time period by 
slowly lowering the upright sample tube into the liquid nitrogen, giving the incoming solid 
the opportunity to expand into the liquid phase. 
 
2.2.4 Mass spectral measurements 
 
Whole-protein electrospray mass spectra were acquired using a Waters Quattro II 
spectrometer operating in positive-ion mode. Samples (10 L) were injected into a flow of 50 
L/min of 50% MeOH/H2O mobile phase and integrated over the first minute of detection. 
Syringe pump mass spectra were obtained with a slow flow of 0.1 mM protein in 50 mM 
ammonium acetate at a rated 50 L/min, directly into the spectrometer. Whole-protein 
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spectra were collected from 500-2000 m/z and were deconvoluted using the MassLinx 
software package after selecting a 1 Da resolution and a 10,000-20,000 Da or 10,000-30,000 
Da calculation window.  Unless otherwise noted, protein samples in 50 mM ammonium 
acetate pH 7.0 buffer were first treated with a 1:10 volume of 1% v/v formic acid 
immediately prior to injection. 
Peptide electrospray and tandem MS/MS spectra were collected by Dr. Furong Sun at 
the Mass Spectrometry Facility at the University of Illinois using a Micromass Q-TOF 
Ultima spectrometer operating in positive-ion mode. This was done after separating the 
tryptic digests with a tandem Vydac reverse-phase HPLC column using an elution method 
described in the HPLC section. All tryptic peptides that exhibited an N-terminal glutamate 
residue (E) exhibited an 18 Da mass loss in all b-type ions containing that residue in the 
MS/MS spectrum, due to the loss of a water molecule upon ionization. 
 
2.2.5 Thiol protection and trypsin digest 
 
Trypsin digests of protein samples and reaction solutions were performed according 
to the following procedure: to a solution of the protein in pH 7.0 buffer (0.2-0.3 mM in ~200 
L) was added 20 equivalents ‘EZ-Link’ maleimide-PEG11-biotin (Thermo Scientific, 
Rockford, IL) (250 mM in DMSO), followed by the addition of one volume equivalent (~200 
L) of 6M GdHCl solution containing 25 mM EDTA.  The resulting solution was allowed to 
stand for two hours, after which the GdHCl, EDTA, and maleimide were removed via 
microcentrifuge concentrator (4x exchanges). Solutions to be digested were exchanged into 
100 mM Tris HCl, pH 8.0.  To a tube of 20 g proteomics-grade trypsin powder (Sigma 
Aldrich, St. Louis, MO) was added 20 L 1 mM HCl, and the resulting solution was added to 
200 L of a given protein aliquot measuring 0.2 to 0.3 mM in protein.  This solution was 
incubated at 37C for 18 hours, after which the trypsin was quenched via treatment of the 
solution with 2 L 2M HCl.  Small holes were punched into the cap of the centrifuge tube, 
and the aliquot was flash frozen in liquid N2 and lyophilized to dryness at 1 torr.  The 
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resulting powder was resuspended in 200 L 50 mM potassium phosphate, pH 2.5 and stored 
at -20C for subsequent HPLC separation and mass spectral analysis. 
 
2.2.6 HPLC analysis 
 
After digestion, peptide samples were separated via reverse-phase HPLC using a 
Vydac C18 column on a Waters HPLC system.  Aliquots of peptide solutions in 50 mM 
potassium phosphate, pH 2.5 were injected (50 µL) into the instrument and separated via a 
linear gradient increase in the polarity of the degassed running solvents. 
 
Table 2.1.  HPLC separation method used for reverse-phase HPLC UV-vis analysis of 
 protein tryptic digests.  
 
Time 
(min) 
Flow Rate 
(mL/min) 
% Solvent A 
(0.05% TFA in 
H2O) 
% Solvent B 
(0.05% TFA in 
45:55 
CH3CN:H2O) 
0 1 100 0 
120.00 1 55 45 
120.01 1 100 0 
140.00 1 100 0 
140.01 0 100 0 
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Table 2.2. HPLC separation method used for reverse-phase tandem MS/MS analysis of protein tryptic 
digests in the Mass Spectrometry Laboratory at the University of Illinois. 
 
Time 
(min) 
Flow 
Rate 
(mL/min) 
% Solvent A 
(0.05% TFA 
in 90:10 
H2O:CH3CN)
% Solvent B 
(0.05% TFA in 
45:55 
CH3CN:H2O) 
0 1 100 0 
120.00 1 55 45 
120.01 1 100 0 
140.00 1 100 0 
140.01 0 100 0 
 
2.2.7 Isotopic deenrichment of product peptides 
 
Isotopically-labeled hydrogen peroxide (H218O2) was purchased from ICON Isotope 
Laboratories (Summit, NJ) as a 90% enriched solution (2%) in water. Solutions of 50 mM 
H2O2 (Fisher Scientific) and H218O2 were prepared and degassed according to the procedure 
outlined in Chapter 1 and taken into the glovebox. The concentration of H2O2 was 
determined in each case using an extinction coefficient of 43.6 M-1cm-1 at 240 nm.  To 
tandem stirred solutions of Cu(I)-protein (0.30 mM in 300 L) in 50 mM ammonium acetate 
was added five equivalent aliquots of H2O2 and H218O2  in the glovebox, and the solutions 
were allowed to stir for 60 minutes.  The reaction solutions were then added to a 0.5 mL 
microcentricon filter membrane (Millipore) and centrifuged for 7 minutes at 13.2 x 103 rpm.  
To the remaining ~50 L solution was added 450 L 50 mM ammonium acetate buffer at pH 
7.00, and the solution was dispersed with a pipette tip.  After another centrifugation, 
redissolution, and centrifugation cycle, the solution was subjected to the cysteine protection 
and trypsin digest procedure outlined in section 2.2.5. 
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In another iteration of the experiments, the reaction solutions were first removed from 
the glovebox and exposed to air for the small molecule removal step and subsequent 
processing. Observed differences in the isotopic distributions between the products of these 
preparations would shed light on the role of molecular oxygen in the generation of the 
observed Cys-SO2H and Cys-SO3H damage profile. 
 
2.2.8 Dimedone labeling experiments 
 
The selective sulfenic-acid labeling agent dimedone (5,5-dimethyl-1,3-
cyclohexanedione, ACROS Organics)  was used to trap formed sulfenic acid species.  
Successful labeling was detected via mass spectrometry, as a captured sulfenyl residue would 
carry an irreversible +138 Da appendage. All sulfenic acid labeling experiments were 
performed under anaerobic conditions. 
A solution of 250 mM dimedone in DMSO was first prepared, degassed, and brought 
into the glovebox. To a preformed solution of target species (0.3 to 0.4 mM in 200-400 L) 
was added 200 equivalents dimedone with stirring.  Next, a 4:1 volume of 6M GdHCl was 
added, and the solution was allowed to stir at 20 C for 2 hours. The small molecules were 
removed via exchange into a target buffer via an Untracentricon membrane (10,000 MWCO).  
In a typical experiment, 50 mM ammonium acetate buffer, pH 7.0 was selected as the buffer 
of choice due to the volatility of the buffering components in the subsequent ESI-MS 
analysis. 
 
2.2.9 Colorimetric H2O2 detection 
 
Consumed H2O2 was measured colorimetrically using the CUPRAC assay, in which a 
Cu(II)-neocuproine complex was selectively reduced by H2O2 to yield a strong chromophore 
in the visible region of the UV-vis spectrum (max = 454 nm,  = 7950 M-1cm-1).43 A 
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calibration curve was first constructed, in which 1.00 mL aliquots of aqueous solutions with 
various H2O2 concentrations were prepared by combining: 500 L H2O, 100 L 100mM 
K/Na phosphate  pH 7.0, 100 L 10 mM CuSO4, 100 L 0.1% m/v neocuproine (ACROS) in 
ethanol, and 100 mL H2O2 standards (10 mM to 2 mM). Solutions were vortexed and then 
allowed to stand for 10 minutes before measuring a 100 L aliquot via UV-vis with no 
dilution factor. 
A452 = 0.0011 [H2O2 (M)] - 0.0420;  R2 = 0.998 
Range of sensitivity: 20 M – 1.00 mM 
 
Because we have observed neocuproine remove copper from protein complexes, 
resulting in a false positive signal, a membrane filtration step was required to extract H2O2 
solutions from reaction mixtures before quantifying H2O2. Suitable results are obtained as 
long as control experiments show no release of copper during the course of a given reaction. 
 
2.3 Results and discussion 
 
2.3.1 A new H2O2-derived adduct from holo-M121G azurin  
 
The first approach our laboratory used to investigate the utility of the azurin scaffold 
for modeling of dioxygenase activity was the addition of hydrogen peroxide to the holo (or 
metallated) forms of the protein.  This widely used “shunt” method allows an already-
reduced dioxygen species to be presented to the metal center and encourages the facile 
formation of metal-hydroperoxo and further oxidized intermediates and products.44 This 
methodology has been used even if the system lacked the capacity for true dioxygen 
reduction. This work aimed to model these intermediates, and/or further tailor the azurin 
scaffold to encourage their formation, with the end goal of engineering tailored oxidase 
   
 
34 
 
function into this model scaffold.  All initial investigations were performed under anaerobic 
conditions. 
When a slight excess (2 equiv.) of H2O2 is added to Cu(II)-wild-type or Cu(II)-
M121G azurin, no significant change in spectrum was observed over the 2 hour investigation 
period with either mutant.  
 
 
Figure 2.4. UV-vis spectra of a solution of (left) Cu(II)-wild-type azurin and (right) Cu(II)-M121G 
azurin before and after anaerobic treatment with 2 equiv. H2O2 for 2 hours. Reactions were performed 
at 20C and with 0.30 mM protein in 50 mM NH4OAc, pH 7.0. 
 
In stark contrast, treatment of Cu(I)-wild-type and Cu(I)-M121G azurins with H2O2, 
resulted in significant, mutant-dependent spectral changes (Figure 2.5). While the colorless 
Cu(I) wild-type protein recovered a significant portion of the LMCT band upon addition of 
H2O2 (~70%), the M121G mutant recovered only ~7% of the LMCT (after accounting for the 
relative difference in extinction coefficient for each species).  These results showed that the 
wild-type protein offered some pathway for single electron oxidation of the Cu(I) protein 
back to intact Cu(II) protein, but full recovery was not obtained. Irreversible and 
uncontrolled peroxidative damage to wild-type holo-azurin with added H2O2 has previously 
been documented,45 but showed that only a fraction of the protein was oxidized, even in the 
presence of excess reductant. M121G azurin, in contrast, exhibited efficient active site 
modification with added H2O2, as evidenced by the formation of new electronic absorption 
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features at 350 nm and 450 nm along with the poor regeneration of the LMCT band. Another 
most notable property of the resulting green-colored M121G reaction solution was rapid 
color loss upon exposure to air. 
 
 
Figure 2.5. UV-vis spectra of a solution of (left) Cu(I)-wild-type azurin and (right) Cu(I)-M121G 
azurin before and after anaerobic treatment with 2 equiv. H2O2 for 2 hours. Reactions were performed 
at 20C and with 0.30 mM protein in 50 mM NH4OAc, pH 7.0. 
 
The M121G cavity mutant’s intriguing properties prompted further investigation into 
the identity and efficiency of formation of the air-sensitive adduct formed with H2O2. 
Addition of H2O2 to Cu(I)-M121G azurin resulted in the formation of a green-colored 
solution, with the visible electronic absorption spectrum dominated by spectral features at 
350, 450, and 615 nm (Figure 2.6). We noted that wavelength maximum for the feature 
observed around 610-630 nm were mutant dependent (WT varied from M121G), which 
further supported assignment as authentic restored LMCT band for each mutant. The color of 
the green reaction solution persisted for several hours, but showed slow lightening thereafter. 
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Figure 2.6. (Left) Kinetic UV-vis spectra upon the anaerobic addition of 2 equiv. H2O2 to Cu(I)-
M121G azurin. (Right) Kinetic trace of species absorbance maxima at 450 nm and 615 nm. 
 
Interestingly, exposing the sample to air resulted in the acute loss of the spectral 
features at 450 nm and 350 nm while those at 615 nm were largely unaffected (Figure 2.7).  
This result demonstrated that the ‘green’ solution was a mixture of an air-sensitive yellow 
species and an air-stable blue species. 
 
Figure 2.7. (Left) Kinetic UV-vis spectra upon exposure of an H2O2 reaction solution to air. (Right) 
Kinetic trace of species absorbance maxima at 450 nm and 615 nm. 
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2.3.2     Optimization of pH and H2O2 stoichiometry for maximum A450 formation 
 
An attempt was made to optimize the pH and added H2O2 equivalents required to 
maximize the amount of newly-identified adduct prepared upon anaerobic addition of H2O2 
to the Cu(I)-M121G protein. The UV-vis absorbance value at 450 nm was used as the handle 
for species formation. Different equivalents of H2O2 were added to solutions of Cu(I)-
M121G azurin (0.30 mM) and allowed to stir until the A450 band had maximized (30-60 
minutes).  A linear trend was observed in the formation of the species up to two equivalents 
of H2O2,(Figure 2.5), after which no further significant increase was observed. These results 
suggested a relatively targeted adduct formation with added peroxide, but adduct formation 
required more than the two oxidizing equivalents one molecule of H2O2 has to offer. To 
support this interpretation, aliquots of the reaction solution after treatment with two 
equivalents H2O2 were filtered through a centricon membrane (10,000 MWCO), and the 
filtrate was analyzed for H2O2 consumption via a neocuproine assay.  As shown in Figure 
2.8, all or most of two added equivalents of H2O2 (0.6 mM) is consumed by the M121G 
mutant over the investigated period, compared to about one total equivalent consumed by the 
wild-type protein over the same period.  
 
  
Figure 2.8. (Left) Maximum yellow chromophore generation as a function of equivalents of added 
H2O2. (Right) Consumption of H2O2 (600 M, 2-equiv. datapoint) by Cu(I)-proteins afte two hours. 
Solutions contained 50 mM ammonium acetate, pH 7.0 and 0.3 mM protein. 
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For the pH study, a ‘universal’ buffer was utilized, compposed of a buffer cocktail 
(20 mM CAPS, 20 mM MOPS, 20 mM MES, 20 mM Tris, and 20 mM sodium acetate), 
capable of spanning a buffering range from 4 to 11 pH units. Two equivalents of H2O2 were 
added to solutions of Cu(I)-M121G in solutions of universal buffer at various pH values, and 
the reactions were allowed to stir until the absorbance at 450 nm had maximized. There is no 
significant change in the total amount of product produced in the pH range of 5-7, but above 
and below this range the formation drops significantly (Figure 2.9). We therefore chose pH 
7.0 as the optimum pH for species generation in further experiments.  
 
Figure 2.9. Maximizing yellow chromophore generation after 2 equiv. H2O2 addition as a function of 
pH.  Spectra were obtained in universal buffer containing 20 mM CAPS, 20 mM MOPS, 20 mM 
MES, 20 mM Tris, and 20 mM sodium acetate. 
 
2.3.3   Resonance Raman spectroscopy reveals a Cu-O interaction in the air-sensitive 
adduct 
 
In an effort to gain more information about the species contained in the solution after H2O2 
addition, reaction solutions were frozen in liquid N2 and sent to Stanford University (in 
collaboration with the Solomon group) to collect their resonance Raman spectra. The visible 
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absorptions we previously observed offered a spectrometric handle for the speciation of the 
products via selective laser irradiation.   
Firstly, the “blue” absorbances characteristic of LMCT bands were investigated by 
laser irradiation of reaction samples at 647 nm.  As can be seen in Figure 2.10, the resonance 
Raman spectrum for Cu(II)-M121G in the Cu-O or Cu-S energy regime shows five well-
resolved vibrations, consistent with a previous literature report for this mutant.46 A solution 
of Cu(I)-M121G azurin after treatment with H2O2 or H218O2 revealed this same spectrum, 
and treatment of the Cu(II) protein with H2O2 also resulted in no spectral change. 
Furthermore, the air-treated adduct sample showed this same vibrational pattern.  These data 
reveal that the electronic absorbance contributions in the 610 to 630 nm wavelength regime 
seen in the UV-vis experiments can be assigned to an authentic unmodified Cu(II)-M121G 
azurin active site. Furthermore, they show that any products obtained from the anaerobic 
treatment of Cu(II)-M121G azurin with H2O2 show no vibrations when irradiated at this 
wavelength. 
        
Figure 2.10. (Left) Resonance Raman spectra of solutions of Cu(II)-M121G azurin (red), Cu(I)-
M121G + 10 eq. H2O2 treatment (blue), Cu(I)-M121G + 10 eq. H218O2 treatment (black), Cu(II)-
M121G + 10 eq. H2O2 treatment (green), and Cu(I)-M121G + 10 eq. H2O2 treatment followed by a 5 
min. treatment with air (purple) upon laser irradiation at 647 nm.  (Right) Zoom-in of resonance 
Raman spectra. All solutions were prepared anaerobically. All oxidant treatments were conducted 
over a 5 min. stirred reaction followed by freeze quenching in liquid N2. Spectra were collected at 77 
K in 50 mM ammonium acetate buffer, pH 5.1. 
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Figure 2.11. (Left) Resonance Raman spectra of solutions of Cu(I)-M121G azurin + 10 eq. H2O2 
treatment (red), and Cu(I)-M121G + 10 eq. H218O2 treatment (blue) upon laser irradiation at 458 nm. 
(Right) Zoom-in of resonance Raman spectra. Spectra were prepared anaerobically. All oxidant 
treatments were conducted over a 5 min. stirred reaction followed by freeze quenching in liquid N2. 
Spectra were collected at 77 K in 50 mM ammonium acetate buffer, pH 5.1. 
 
Next, resonance Raman spectra were collected upon irradiation at 458 nm for those 
samples that exhibited an absorbance maximum at 450 nm upon treatment with H2O2. As can 
be seen in Figure 2.11, The sample of H2O2-treated Cu(I)-M121G azurin showed two well-
resolved vibrations at  at 376 cm-1 and 410 cm-1.  Importantly, no O-O) vibrations were 
observed, which suggested that the species does not contain a superoxo or peroxo unit.  
Features observed upon irradion at 458 nm were immediately lost upon exposure to oxygen, 
allowing direct assignment of the vibrations to the UV-vis contribution at 450 nm. 
Interestingly, when H218O2 was used as the oxidant, these vibrations shifted to a lower 
frequency, and were observed at 373 cm-1 and 398 cm-1 (Figure 2.11). Furthermore, an 
intensity redistribution was observed between the two vibrations. We and the Solomon group 
speculate that this may be the result of a Fermi resonance, arising from two vibrations  whose 
origins are in close proximity.47 As these vibrations are in the energy regime for a Cu-S or 
Cu-O vibration and exhibit isotopic shifts, the collective data strongly suggest a Cu-O 
   
 
41 
 
interaction, with the origin of the added oxygen being H2O2 (summarized in Table 2.3). The 
isotopic shift, which was up to 12 cm-1, was in an acceptable range for intuitive candidate 
Cu-O interactions,48 including copper superoxo complexes reported by the Karlin Group or 
copper peroxo complexes, but the lack of an O-O stretching vibration, along with the 
temperature regime of stability, shed doubt on the assignment of the adduct as a superoxo or 
hydroperoxo species.  
Table 2.3. Summary of resonance Raman spectra obtained for frozen solutions of M121G 
azurin and select reactions, obtained at 77 K upon laser irradiation at select wavelengths. 
Reaction Vessel   
(nm) 
 (Cu-S or Cu-O) 
(cm-1) 
Cu(I)-M121G 458  -- 
Cu(II)-M121G 458  -- 
Cu(I)-M121G + H216O2 458 376, 410 
Cu(I)-M121G + H218O2 458 373, 398 
Cu(I)-M121G + H216O2  + air 458 -- 
   
Cu(I)-M121G 647 -- 
Cu(II)-M121G 647 347, 368, 397, 426 
Cu(I)-M121G + H216O2 647 347, 368, 397, 426 
Cu(I)-M121G + H218O2 647 347, 368, 397, 426 
Cu(I)-M121G + H216O2  + O2 647 347, 368, 397, 426 
 
These data were instrumental in our continued interest in identifying the species, 
because the spectral parameters and thermal stability properties of the air-sensitive complex 
were otherwise unlike target Cu(II)-superoxo and Cu(II)-peroxo complexes. 
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2.3.4  EPR spectroscopy reveals an axial, Cu(II)-containing adduct 
 
The observed bands in the UV-vis spectrum suggested a paramagnetic copper 
complex, suitable for structural analysis via Electron Paramagnetic Resonance (EPR) 
spectroscopy. Spectra of frozen reaction solutions were collected at various time points after 
oxidant addition, and revealed gradual formation of two major axial Cu(II) species (Figure 
2.12).  Simulation of the two species by Mark Nilges at the EPR center at the University of 
Illinois allowed spectral parameters to be extracted (Table 2.4). As the adduct of interest was 
air sensitive, an aliquot sample frozen after five minutes was thawed aerobically for 5 more 
minutes at 20 C, and the sample was refrozen in liquid N2. The resulting spectrum (Figure 
2.12) showed that one axial species completely disappeared as the other species formed.  A 
difference spectrum visualized the air-sensitive portion of the paramagnetic copper in 
solution. 
 
Figure 2.12. (Left) Time-resolved X-band EPR spectra of a solution of Cu(I)-M121G after the 
addition of 40 eq. H2O2. Reactions were performed anaerobically in an unstirred EPR tube and 
quenched via freezing in liquid N2. Spectra were collected at 30 K and were an average of 10 scans. 
(Right) EPR spectra of A) the 5-minute H2O2 reaction solution, B) solution A after thawing under air 
and refreezing, and C) the difference spectrum of A - C. Reactions were performed in 50 mM 
ammonium acetate, pH 5.1. 
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Table 2.4. Summary of UV-vis and EPR spectral parameters for select complexes. 
Complex  (max, )  
(nm, M-1cm-1) 
 gx gy gz Az(G) 
Cu(II)-Wild Type 625 (5700) 2.035 2.052 2.263 54 
Cu(II)-M121G  615 (4360); 454 
(500) 
- - 2.270 53 
A450 species 450 (820) 350 (400) 2.025 2.038 2.169 131 
A450 species + air 260 (n.d.) 2.032 2.080 2.351 135 
CuSO4 215 sh 2.059 2.075 2.353 158 
 
The EPR parameters were very similar to tetragonal N2S2 copper complexes,49 
although only one sulfur atom was presumed available for bonding to the copper ion. The 
most informative extracted parameter for the air-sensitive species is the low value of 2.169 
for the gz parameter. This parameter strongly suggests at least one Cu-S interaction49, 50 as gz 
can be decreased through spin delocalization onto a ligating sulfur d-orbital as radical 
character increases. When combined with the results of the resonance Raman experiments, it 
was evident that spectral evidence supports both oxygen and sulfur coordination to copper 
ion in the complex.  We presumed Cys-112 supplied a ligating sulfur atom, while the nature 
of the coordinating oxygen atom(s) remained unknown.  We investigated the oxygen atom 
source through mass addition using electrospray mass spectrometry. 
 
2.3.5  Mapping the oxidative damage to the M121G scaffold via trypsin digest and 
mass spectrometry 
 
A sample of the reaction solution was removed from the glovebox and injected into 
an ESI mass spectrometer. The resulting spectrum (Figure 2.13.b) showed +16 Da mass 
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additions, indicative of O-atom additions.  The spectrum was dominated by a +48 Da 
modification which strongly suggested a single residue site had been modified with three 
oxygen atoms (Figure 2.13). In contrast, the wild type protein under the same conditions 
(Figure 2.13.d,e) was much more resilient to oxidative modification, and showed only slight 
damage in the form of a +16 Da modification to the scaffold. The degree of scaffold 
oxidation is consistent with a literature report, which documented resilience of the native 
scaffold to oxidative damage from added hydrogen peroxide and ascorbic acid.51  
A demetallation and trypsin digest of the Cu(I)M121G construct before and after 
H2O2 treatment was performed in order to identify the modified residue locations. HPLC 
chromatograms of the digest were compared before and after H2O2 treatment (Figure 2.14). 
As we and others45 found difficulty in interpreting high-traffic and low-intensity HPLC-UV-
vis spectra in the region of interest, modifications to the azurin scaffold were identified via a 
global mass comparison of HPLC-MS/MS spectra for a digest using H2O2 and H218O2.  All 
mass differences between the two isotopic data sets were interpreted as peroxidative damage. 
 
Figure 2.13. Syringe-pump ESI-MS spectra of Cu(I)-azurins upon anaerobic treatment with 2 eq. 
H2O2 for 120 minutes, followed by air exposure. Shown are Cu(I)-M121G azurin a) before and b) 
after treatment, and Cu(II)-wild type c) before and d) after treatment. 
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Figure 2.14. HPLC trace of the tryptic digest of Cu(I)-M121G upon addition of 0, 2, and 10 equiv. of 
H2O2.  Solutions were demetallated prior to digest. 
 
Table 2.5. Summary of H2O2-modified residues after the anaerobic addition of 2 equiv. H2O2 to 
Cu(I)-M121G azurin; these are located through 16O/18O isotopic differentiation. 
Residue 
Location 
Residue 
Mod 
# O’s 
H2O2 
Tr(min) 
(ID) 
Obtained  
m/z 
(H216O2) 
Calcd. 
m/z 
(16O) 
Obt  m/z 
(18O) 
Calcd. 
m/z 
 ( 18O) 
1-24; 25-27 
( -S-S- ) 
Met13- SO 1 50.51 
(A) 
1497.0 
(+2H+) 
 
1497.14 
(+2H+) 
1497.9 
(+2H+) 
 
1498.14 
(+2H+) 
 
42-70 Met46-SO 1 83.57 
(C) 
1511.9 
(+2H+) 
 
1511.70 
(+2H+) 
1512.9 
(+2H+) 
 
1512.70 
(+2H+) 
 
42-70 Met64-SO 1 89.83 
(C’) 
1511.9 
(+2H+) 
 
1511.70 
(+2H+) 
1512.9 
(+2H+) 
 
1512.70 
(+2H+) 
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104-122 Cys112-SO2 1,2 79.32 
(B) 
1091.1 
(+2H+) 
 
1091.20 
(+2H+) 
Mix 1093.20 
(+2H+) 
04-122 Cys112-SO3 1,2,3 78.11 
(B) 
1099.7 
(+2H+) 
 
1099.72 
(+2H+) 
Mix 1102.60 
(+2H+) 
 
Shown in Table 2.5 are five residue modifications identified after H2O2 treatment of a 
solution of Cu(I)-M121G with H2O2. Peptides containing sulfoxide modifications to Met 13, 
Met 46, and Met 64 were found, as well as peptides containing modifications to Cys-112.  It 
is noteworthy that all of these residue are located within 10 A of the active site pocket, 
suggestive of copper-generated scaffold damage in a folded construct, as opposed to 
promiscuous radical damage. 
 
2.3.6 Isotopic deenrichment study shows air-assisted generation of Cys-SO3H  
 
The observation of a mixture of 16O and 18O in the Cys-SO3H- and Cys-SO2H-
containing tryptic peptides when using H218O2 as the initial oxidant (Table 2.5) offered a 
hypothesis that these sulfinic and sulfonic acid residues were the result of the aerobic 
degradation of the air-sensitive compound under investigation.  To address this, the oxidation 
reaction was again performed with isotopically-labeled H218O2, and partitioned between an 
anaerobic workup in the glovebox and an aerobic workup outside of it (Figure 2.15). In the 
latter case, the reaction solution was removed from the glovebox and exposed to air and non-
degassed buffers prior to demetallation and digest. 
 
 
 
     Table 2.5 (contd.) 
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H218O2
Cu(I)-M121G
aerobic
workup
anaerobic
workup
Cys-SOx
fragment analysis
digest
digest
Cys-SOx
fragment analysis
 
Figure 2.15. Strategy for investigating the role of air in forming the Cys-SOx product profile from the 
oxidation of Cu(I)-M121G azurin with labeled H2O2. 
  
Figure 2.16 shows the 13C isotopic distributions for the Cys-SO2H-containing tryptic 
peptide.  Its presence established that some amount of this peptide is produced even 
anaerobically under these conditions (a 5 equivalent excess of H2O2) although it was difficult 
to quantify due to a low peptide population and high congestion in the HPLC separation. 
When H218O2 was used and the solution was worked up anaerobically, Cys-S18O2H was the 
only product observed (Figure 2.17.B) (bearing in mind that calculations assumed a 90% 
atom labeling efficiency in each instance of an O-atom insertion), as evidenced by a shift of 
the monoisotopic mass of the peptide by +4 Da with a labeled oxidant. No significant change 
was observed in the isotopic distribution between anaerobic and aerobic workups.   
Figure 2.17 shows the 13C isotopic distributions for the Cys-SO3H-containing tryptic 
peptides obtained using the same experiments as previously described. Here, significant 
differences in the isotopic distributions were observed between the two workups (Figure 
2.18.B and 2.18.D).  We observed that a large population of Cys-S18O16O2H peptide was 
built up in the aerobic sample, but was virtually absent in the sample worked up 
anaerobically. 
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Figure 2.16. Isotopic distribution for product [104-122]-SO2H product tryptic peptide generated from 
A) addition of 5 eq. H2O2 to Cu(I)-M121G azurin and anaerobic workup, B) addition of 5 eq. H218O2 
to Cu(I)-M121G azurin and anaerobic workup, and C) addition of 5 eq. H218O2 to Cu(I)-M121G 
azurin and aerobic workup.  The H218O2 containing solution worked up under aerobic conditions 
contains a similar 18O distribution to that worked up under anaerobic conditions. Monoisotopic 
masses are highlighted. 
 
Figure 2.17. Isotopic distribution for product [104-122]-SO3H product tryptic peptide generated from 
A) addition of 5 eq. H2O2 to Cu(I)-M121G azurin and anaerobic workup, B) addition of 5 eq. H218O2 
to Cu(I)-M121G azurin and anaerobic workup, and C) addition of 5 eq. H218O2 to Cu(I)-M121G 
azurin and aerobic workup.  The H218O2-containing solution worked up under aerobic conditions 
contained a significant population of Cys-S18O16O2H product peptide. Monoisotopic masses are 
highlighted. 
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The experiments were repeated using a single equivalent of oxidant in an effort to 
minimize the population of purely peroxidative Cys-S18O3H-containing fragment peptide. As 
can be seen in Figure 2.18, a nearly pure isotopic spectrum of Cys-S18O16O2H is formed 
under these conditions.  These results, taken together, suggest that with low equivalents of 
H2O2, sulfonic acid (Cys-SO3H) is produced when a Cys-18SO unit is aerobically oxidized, 
whereas sulfinic acid (Cys-SO2H) is not. Higher equivalents of H2O2 may produce sulfinic 
and sulfonic acid directly by further oxidizing any Cys-SOH that was produced in the 
reaction. 
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Figure 2.18. Calculated and experimental isotopic distributions for product [104-122]-SO3H tryptic 
peptides [(pep) + 2H+]+2 with progressive 18O labeling.  Experimental spectra were obtained with 1 
eq. additions of H216O2 or H218O2 to Cu(I)-M121G and an aerobic workup. 
 
2.3.7 Derivatization of sulfenic acid with the selective labeling agent dimedone 
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It is well established that sulfenic acid moieties exhibit a unique electrophilic capacity 
at their sulfur atom, and this has been exploited with the selective labeling agent dimedone.52, 
53 A mass addition of +138 Da from the irreversible and selective condensation of a sulfenic 
acid with dimedone can be tracked alone via mass spectrometry, or can be tracked via 
tethering of dimedone to various beacon systems.3,  23 Treatment of the product of Cu(I)-
M121G azurin and H2O2 with this reagent allowed for derivatization and a crude inference of 
reaction yield via mass spectral analysis. Labeling was unsuccessful with folded proteins (not 
shown), presumably due to a lack of access to the sulfenic group, so we used a procedure in 
which the sulfenic-containing adduct was unfolded with 6M GdHCl in the presence of an 
excess of dimedone.  This procedure resulted in the capture of a diagnostic amount of 
dimedonylated material, evidenced by a +138 Da modification to the azurin scaffold (Figure 
2.19). A control experiment with wild-type azurin showed no dimedone capture upon 
treatment with H2O2 and unfolding, and this result was critical in demonstrating that the 
sulfenic moiety did not form through processes involving unfolded protein. Tryptic digest 
and tandem MS/MS analysis confirmed that the sulfenic acid modification was isolated to the 
Cys-112 residue (Figure 2.20).  Furthermore, we showed that the removal of the reaction 
solution from an aerobic atmosphere compromised sulfenic acid detection by dimedone. 
 
 
Figure 2.19. ESI-MS of Cu(I)-wild-type (left) and Cu(I)-M121G azurin (right) after anaerobic 
treatment with 2 eq. H2O2 followed by size exclusion chromatography (PD-10 column) and unfolding 
with 6M GdHCl in the presence of 100 eq. dimedone.  Solutions were 0.3 mM in protein at 20C.  
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Capture of dimedone (evidenced by a +138 Da modification) was observed only in the M121G 
mutant. 
 
 
 
Figure 2.20. QTOF ESI-MS spectrum (top left) and tandem MS/MS (bottom) of [104-122]-
dimedonyl tryptic peptide [(pep)+2H+]+2 from M121G azurin showing modification to Cys-112.  
Dimedonylated product detection was compromised with an aerobic sample workup (top right). 
 
These results definitively established the sulfenic group as the predominant protein 
modification to M121G upon addition of H2O2 to the Cu(I) form.  The sulfenic group formed 
is chemically reactive, but may show shape and size selectivity toward added reagents due to 
its location within the cavity of the azurin scaffold.  
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2.3.8 Biomimetic reduction of azurin sulfenic acid by ascorbate 
 
It has been shown that sulfenic acids are reduced back to thiols in a cellular context 
via condensation with a molecule of thiol to produce a disulfide linkage which cellular 
thioredoxins can readily process.54 Alternatively, some sulfenic-acid-containing enzymes 
(such as NADH peroxidase (Npx)) have shown direct reduction to a thiol without forming 
disulfide intermediates.  It has been shown that FADH2 mediates a hydride transfer from 
NADH to the sulfenic acid, producing a hydroxide ion and the reduced thiol product.2, 54, 55 In 
a landmark report in 2007, ascorbic acid was shown to be the direct biological reductant of 
the sulfenic-acid form of a class of redox-signaling peroxiredoxins (Pxrs).56 This report was 
pivotal in showing that redox sensing was not bound to thiol reduction events. That is, 
sulfenic acids offered a new regime of solely H2O2/ascorbate-dependent redox cycling, an 
oxidative stress equilibrium that has yet to be thoroughly explored.56 
One literature example cited the reduction of a metal-coordinated sulfenate group.31  
Reduction of the prototype compound Co(III)(en)2(Cys-SO) with added chromium(II) was 
shown to ultimately produce cysteine after two molecules combined to form sulfenyl radical, 
and a connection was drawn to the antioxidant effect of sulfur compounds in protecting 
protein metal centers from reactive radicals. 
In light of such reports, we investigated the effect of treating the formed Cu(II)-(SO)-
M121G species with ascorbate under anaerobic conditions without the presence of an 
electron mediator. Treatment of a green solution of generated species with 50 equivalents of 
sodium ascorbate resulted in a gradual loss of color over ten minutes with stirring.  After an 
additional two hours, small molecules were removed with size-exclusion chromatography. 
The UV-vis spectra in Figure 2.21 show no features in the visible region, indicating either a 
loss of metal ion, or the successful reduction of the generated species.  To determine which 
explanation was accurate, two equivalents of H2O2 were again added in a second oxidative 
treatment.  As can be seen, a green-colored solution is again generated, with absorbance 
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maxima at 450 nm and 615 nm. However, this solution only recovered ~70% of the color. An 
increased shoulder from 300-350 nm in the second treatment of H2O2 is perhaps indicative of 
protein unfolding or degradation. Nevertheless, these results suggest that the copper-ligated 
sulfenic acid group can be reduced to a thiolate with added ascorbate. 
 
Figure 2.21. Reversibility of sulfenic acid functionalization: A solution of Cu(I)M121G  (black) was 
treated with 2 equiv. H2O2 under anaerobic conditions for 2 hours (red).  The solution was treated 
with 50 equiv. sodium ascorbate for 2 hours, followed by size exclusion chromatography  to yield 
colorless material (blue). To this material was added 2 equiv. H2O2 to again generate a green colored 
solution (green). 
 
2.4  Summary 
 
In summary, we have shown that the addition of H2O2 to an anaerobic solution of 
Cu(I)-M121G azurin, a cavity mutant, efficiently modifies the Cys-112 to sulfenic acid. The 
requirement for a reduced copper ion for the observed transformation suggests reduction of 
hydrogen peroxide and O-O bond cleavage to generated ROS species capable of protein 
oxidation.  Although the protonation state of the sulfenic acid is unclear at this time, we have 
established that the moiety is ligated to copper ion, evidenced by UV-vis, resonance Raman, 
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and EPR spectroscopy. Figure 2.23 is a computer model of the generated species, designed 
using crystal structure parameters for Cu(II)-M121G azurin and a coordinated sulfenato 
group from a Co-containing thiocyanate hydrolase.6 
 
 
 
Figure 2.22. Hosting the first designed proteinic sulfenate group: A) Crystal structure of Cu(II)-
M121G azurin and B) model of Cu(II)SO-M121G azurin. The latter was generated using crystal 
parameters for Cu(II)-M121G azurin and crystal parameters for a coordinated sulfenate group from 
Co-containing thiocyanate hydrolase (ref. 6, 57)  
 
Exposure to air rapidly degrades the cysteine sulfonic acid, as evidenced by isotopic 
deenrichment studies using H218O2.  The sulfenate unit can be captured upon unfolding the 
protein in the presence of the diagnostic labeling agent, dimedone.  Once the Cu(II)(SO)-
M121G complex is formed, the copper and sulfenate groups can be reduced back to the 
Cu(I)-M121G starting material with added ascorbate in a biomimetic fashion with respect to 
the sulfenate group. This is the first example of a copper-stabilized sulfenic acid group, and 
the first example in which this reactive and important post-translational modification has 
been incorporated into a designed protein scaffold. 
Our future work with this system is focused on using this sulfenic acid in the design 
of a biomimetic peroxidase system capable of multiple substrate turnovers. 
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Chapter 3. Design of a three-histidine framework in azurin: toward 
modeling activation and insertion of dioxygen 
 
3.1 Introduction 
 
3.1.1 Towards oxidase modeling in the azurin scaffold 
 
As observed when investigating modification inflicted to the M121G azurin scaffold 
by H2O2, methionyl and cysteinyl residues near the active site copper ion can be susceptible 
to oxidative modification and may alter the protein structure and subsequent data 
interpretation. Despite a required coordinating Met-residue in the native PHM and DM 
enzymes,1, 2 Nature manages to circumvent modification to this critical but easily oxidizeable 
residue during the catalytic cycle. This mentioned, successful synthetic model ligands sets 
capable of hosting copper bound reactive oxygen species have exclusively exhibited solely 
nitrogen donor ligand sets. We envisaged that a C112H azurin scaffold would introduce a 
strong copper-binding site exhibiting a nearly planar 3-His geometry, and would offer a 
strategy for removal of the ‘redox chameleon’3 cysteinyl residue. While the desired 3-His 
copper site is structurally more similar to the CuB site of PHM4 (thought to serve as an 
electron transfer site) than the proposed oxygen-activating CuA site, we were also interested 
in the capacity of the designed 3-His site to host biomimetic dioxygen reduction and oxygen 
insertion based on model successes.  
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Figure 3.1 Hydroxylation reaction catalyzed by DM and PHM enzymes, thought to proceed along 
the same chemical pathway.5 
 
3.1.2 The C112H/M121X series offers an intramolecular substrate 
 
 
We sought to model the dioxygen insertion reaction (Figure 3.1) in the small scaffold 
protein azurin, and utilize axial azurin mutations to generation open binding sites at copper 
for dioxygen binding and reduction.  We placed a series of intramolecular ‘substrate’ 
residues in close proximity to the copper active site (M121G, M121V, M121F). These 
residues offered abstractable hydrogen atoms (Figure 3.2)6‐9 and were non-coordinating 
residues, thus liberating the copper ion from coordinative saturation.   
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Figure 3.2. Lewis structures for active sites of wild type azurin and designed C112H/M121X mutant 
series showing replacement of equatorial cysteine ligand with histidine and presentation of 
intramolecular substrate. 
 
Thus, we hoped to combine all necessary components required to observe and study 
biomimetic dioxygen activation and insertion in the ‘converted’ azurin scaffold. We provided 
dioxygen via saturation of the solution with O2(g), and electrons in the form of dissolved 
ascorbate, as well as the potential of the protein itself to serve as a reductant to another 
oxygen-reducing protein molecule. This intramolecular substrate approach would allow for 
facile analysis of oxidative modification to the whole protein and tryptic digested peptide 
fragments by mass spectrometry.  We envisioned that this step would lead naturally to the 
engineering of intramolecular substrate oxidation. 
We have successfully engineered a 3-His copper binding site in azurin, and show 
spectral evidence for a trigonal planar geometry.  Although a series of axial intramolecular 
substrate mutations (C112H/M121X (where X=M, G, V, F)) resulted in variants with nearly 
identical copper geometry, the series demonstrated mutant-dependent scaffold modification 
upon exposure to oxygen and electrons in the form of ascorbate. The binding and reduction 
of dioxygen at the Type-2 sites models the first mechanistic steps of PHM and DM using 
Nature’s toolbelt, and shows progress towards the goal of a functional model. 
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3.2 Experimental 
 
3.2.1 Mutagenesis and protein preparation 
 
Mutations were prepared on the wild type azurin template plasmid (pet9a vector) 
using the Quickchange site-directed mutagenesis method.  The primers used to generated the 
C112H/M121X series were: C112H: fwd-5’-TAC-ATG-TTC-TTC-CAT-ACT-TTC-CCG-
3’, M121G: fwd-5’-CAC-TCC-GCA-CTG-GGG-AAA-GGT-ACC-3’, M121V: fwd-5’-
CAC-TCC-GCA-CTG-GTG-AAA-GGT-ACC-3’, M121F: fwd-5’-CAC-TCC-GCA-CTG-
TTC-AAA-GGT-ACC-3’ along with the reverse complement backward primer. Mutations 
were confirmed by plasmid sequencing at the DNA Sequencing Laboratory at the University 
of Illinois using a T-7 promotor target.  Proteins were prepared according to the azurin 
purification procedure outlined in Chapter 1, and their indenties confirmed via ESI-MS 
analysis. 
Holo-proteins were prepared via addition of a slight excess (3 equiv.) of CuSO4 (50 
mM stock solution) to a stirred solution of 0.3 mM apo protein at 4 C.  After stirring for 30 
minutes, excess copper was removed via size exclusion chromatography using a PD-10 
column. Protein was quantified via extinction coefficient of 280 = 9800 M-1cm-1.10 
 
3.2.2 Spectroscopy measurements 
 
UV-vis absorption spectra were obtained at 20 C on an HP Agilent 8453 diode array 
spectrometer. X-band EPR measurements were collected at 30 K on a Varian-122 
spectrometer equipped with an Air Products Helitran cryostat and temperature controller, 
with a collection frequency of 9.044 GHz and 100 kHz field modulation. EPR spectra were 
recorded in 25% glycerol as a glassing agent. All UV-vis spectra were recorded in 50 mM 
ammonium acetate, pH 5.1 unless otherwise noted. EPR spectra were simulated with the 
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automated fitting program, SIMPOW6,11,  12 and program developed at the University of 
Illinois based on POW and MPOW software. 
 
3.2.3 Cyclic voltammetry 
 
Electrochemical experiments were performed using a CH Instruments Model 620A 
Electrochemical Analyzer (Austin, TX). Experiments were performed at 4 C with a normal 
three-electrode configuration consisting of an edge-plane graphite working electrode 
(diameter = 2 mm), a Ag/AgCl electrode (Bioanalytical Systems, Inc., 3M NaCl) as a 
reference electrode, and a platinum-wire auxiliary electrode (CH Instruments). Experiments 
were performed in a Faraday cage to minimize external electrical noise.  The working 
electrode was polished with 0.05 M alumina (Buhler, Lake Bluff, IL) prior to use.  After 
sonication for 10 minutes, the electrode was rinsed with water and blown dry with air.  A 2 
L sample of 0.1-0.2 mM sample protein was added to the working electrode and allowed to 
stand for 5 minutes.  The working electrode was then inserted into a degassed solution of 
buffer and the CV experiment was performed. 
Electrode voltage was cycled between -0.5 V and +0.6 V vs. Ag/AgCl electrode with 
a scan rate of 500 mV/sec.  The values of reduction potential, Em, were calculated using the 
formla (Epa + Epc)/2, where Epa and Epc are anodic and cathodic potentials, respectively. 
Averages shown are three wave averages for three separate measurements. 
 
3.2.4 Mass spectral measurements 
 
Whole protein electrospray mass spectra were acquired using a Waters Quattro II 
spectrometer operating in positive ion mode. Samples (10 L) were injected into a flow of 50 
L/min of 50% MeOH/H2O mobile phase and integrated over the first minute of detection. 
Whole protein spectra were collected from 500-2000 m/z and were deconvoluted using the 
MassLinx software package after selecting a 1 Da resolution and a 10000-20000 Da or 
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10000-30000 Da calculation window.  Unless otherwise noted, protein samples in 50 mM 
ammonium acetate pH 7.0 buffer were first treated with 1/10 volume of 1% v/v formic acid 
immediately prior to injection. 
Peptide electrospray and tandem MS/MS spectra were collected by Dr. Furong Sun at 
the Mass Spectrometry center at University of Illinois, using a Micromass Q-TOF Ultima 
spectrometer operating in positive ion mode, after prior separation of tryptic digests with a 
tandem Vydac reverse phase HPLC column using an elution method described in the HPLC 
section. All tryptic peptides that exhibited an N-terminal glutamate residue (E) exhibited 
an18 dalton mass loss in all fragments containing that residue in the MS/MS spectrum, due to 
the loss of a water molecule upon ionization. 
 
3.2.5 Trypsin digest 
 
Trypsin digests of protein samples and reaction solutions were performed according 
to the following procedure:   To a solution of the protein in pH 7.0 buffer (0.2-0.3 mM in 
~200 L) was added 20 equiv. ‘EZ-Link’ maleimide-PEG11-biotin (Thermo Scientific, 
Rockford, IL) (250 mM in DMSO) followed by addition of one volume equivalent (~200 L) 
of 6M Gd·HCl solution containing 25 mM EDTA.  The resulting solution was allowed to 
stand for two hours, after which the Gd·HCl, EDTA, and maleimide were removed via 
microcentrifuge concentrator (4x exchanges). Solutions to be digested were exchanged into 
100 mM Tris·HCl, pH 8.0.  To a tube of 20 g proteomics-grade trypsin powder (Sigma 
Aldrich, St. Louis, MO) was added 20 L 1 mM HCl, and the resulting solution was added to 
200 L of a given protein aliquot measuring 0.2 to 0.3 mM in protein.  This solution was 
incubated at 37 C for 18 hours, after which the trypsin was quenched via treatment of the 
solution with 2 L 2M HCl.  Small holes were punctured into the cap of the centrifuge tube, 
and the aliquot was flash frozen in liquid N2 and lyophilized to dryness at 1 torr.  The 
resulting powder was resuspended in 200 L 50 mM potassium phosphate, pH 2.5 and stored 
at -20 C for subsequent HPLC separation and mass spectral analysis. 
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3.2.6 Reactivity assays with O2/sodium ascorbate 
 
Solutions (2.00 mL) of metallated protein in 50 mM ammonium acetate, pH 6.4 were 
treated with 100 equivalents sodium ascorbate, and stirred in a Thumberg cell under an O2(g) 
saturated atmosphere for 60 minutes.  Excess sodium acetate was removed with rigorous 
exchange into 50 mM ammonium acetate, pH 6.4, via a microcentrifuge filtration membrane 
(x4) (10,000 MWCO).  Resulting reaction solutions were directly analyzed via ESI-MS, or 
exchanged in the same manner into 100 mM TrisHCl for trypsin digest. 
  
3.3 Results and discussion 
 
3.3.1    Computer modeling and simulation suggests a 3-His coordination mode in 
C112H/M121X series 
 
Prior to mutagenesis, the C112H, C112H/M121G, C112H/M121V, and 
C112H/M121F mutations were incorporated into the wild type azurin crystal coordinates in 
silico using the computer software package, VMD.13 The resulting energy minimized 
structures were exposed to a 10 Å digital water cube and exposed to molecular dynamics 
simulations.  The resulting energy minimized structures after simulation are shown in Figure 
3.3. 
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Figure 3.3. Energy minimized models of Zn(II)-C112H/M121X azurin series, generated using VMD 
software. 
 
Table 3.1. Select bond distances in designed models for C112H/M121X azurin series 
showing metal coordination and distance to axial hydrogen atom source. 
 
Variant PHM 
(CuM)4 
PHM 
(CuH)4 
C112H C112H/ 
M121G 
C112H/ 
M121F 
C112H/ 
M121V 
M-N 2.15 H242 2.01H107 2.08H46 2.09 2.13 2.13 
M-N 2.22 H244 2.60H108 2.27H112 2.11 2.27 2.27 
M-N /S 2.38 S314 2.11H172 2.17H117 2.16 2.16 2.17 
M-H  - - 6.16(HB) 
7.01(HA)
5.41(HB1), 
5.49(HB2) 
4.34(HG11), 
4.72 (HG21) 
5.32(HB) 
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All variants exhibited a three-histidine trigonal plane, in which the metal ion is 
bound through the N positions on the imidazole rings. Other protonation states required 
independent modeling and showed loss of metal ion from the active upon exposure to 
molecular dynamics conditions.  The observed geometries are reminiscent of Type-2 copper 
sites found in biology.14 As can be seen in the models, the hydrogen atoms are poised in an 
axial position relative to the copper-histidine plane; their relative distances from the metal 
ion reported in Table 3.1. These models gave results that supported preparation of the 
proteins for further investigations. 
 
3.3.2 UV-vis and EPR analysis reveal C112H/M121X series are Type-2 copper   
centers 
 
All four azurin mutants in the designed series bound copper(II) ion, as first evidenced 
qualitatively by immediate formation of a slight blue color upon treatment with CuSO4, 
which was retained with the protein fraction after passage through a size-exclusion column. 
UV-vis spectra of the resulting solutions (Figure 3.4) showed broad, low-intensity (~ 100 
M-1cm-1) visible bands with wavelength maxima around 650-700 nm, characteristic of 
formally parity forbidden d-d* Cu(II) transitions.15‐17 No high intensity transitions were 
observed in the visible spectrum, as expected from removal of the potential for Cys(S)-Cu 
ligation. All mutants showed similar spectral properties (Table 3.2), although C112H/M121G 
variant exhibited a max that was 15 nm lower in energy than the others in the series.  We 
noted this difference may be evidence of a copper-coordinated water molecule. 
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Figure 3.4. UV-vis spectra of Cu(II)-C112H/M121X azurin series.  The inset shows a 10x 
concentrated sample which allowed for resolution of low intensity blue transitions. Solutions were 0.1 
mM and 1.0 mM in protein and spectra were obtained in 50 mM ammonium acetate, pH 6.4 at 20 C. 
 
Table 3.2. Visible absorption spectral parameters for Cu(II)-wild type azurin and 
C112H/M121X variants 
 
Azurin Variant max (nm)   ( M-1cm-1) 
Wild Type Az18 625 5300 
Cu2Zn2SOD19 680 150 
C112H 660 120 
C112H/M121G 675 130 
C112H/M121F 660 180 
C112H/M121V 660 180 
 
EPR spectra of the protein series showed typical axial Type-2 copper centers, as 
evidenced by fingerprint ‘uncontracted’ Az values in the range of ~130-170 G (Figure 3.5).20, 
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21 The g-values for C112H/M121G azurin were virtually identical to those of copper ion in 
bovine Cu/Zn-SOD,19, 22 which exhibits and nearly planar 3-His trigonal planar geometry with 
an axially bound water molecule although other structural differences are present.  This data 
suggests that the Cu(II)-C112H/M121G variant may exhibit a bound water molecule, as 
revealed in the crystal structure of the Cu(II)-M121G azurin variant (See Chapter 1).  It is 
also interesting to note that the EPR profile for the mutant series are in general quite similar, 
and resembled ammonia ligated free copper in solution (Figure 3.5). and species were most 
informatively distinguished via their Ax value, which may suggest a weakly bound ligand 
present in the C112H/M121G (Ax= 1 G) and C112H (Ax = 1 G) variants, but absent in 
C112H/M121V (Ax = 14 G), and C112H/M121F (Ax = 16 G) variants. 
 
Figure 3.5.  X-band EPR spectra of C112H/M121X azurin series, collected at 30 K as an average of 
30 scans. Simultation of experimental data performed in the EPR center at University of Illinois. 
Spectra were collected on 0.3 mM protein solution in 50 mM ammonium acetate buffer, pH 6.4, 
containing 25 % glycerol as a glassing agent. 
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Table 3.3.  EPR spectral parameters obtained through simulation of experimental data for 
C112H/M121X azurin series 
 
Azurin Variant gx gy gz Ax (G) Ay (G) Az (G) 
CuSO4 in NH4OAc 2.059 2.002 2.370 9 9 142 
Cu2Zn2SOD23 2.083 - 2.271 - - 140 
Wild Type Az 2.035 2.052 2.263 8 8 54 
C112H Az 2.024 2.068 2.293 1 11 159 
C112H/M121G Az 2.023 2.072 2.294 1 18 158 
C112H/M121F Az 2.027 2.067 2.294 14 2 153 
C112H/M121V Az 2.020 2.069 2.295 16 12 149 
 
 
3.3.3 Cyclic voltammetry reveals modest increase in reduction potential for 
C112H/M121X variants from wild type azurin 
 
The reduction potentials for each member of the series was determined to investigated 
the effect of the C112H mutant and the accompanying axial mutants.  As can be seen in 
Table 3.3, the C112H/M121X series exhibit Em values in the range of 400 - 430 mM vs. 
NHE.  This modest increase from wild type azurin is characteristic of Type-2 copper centers 
in biology. 
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Table 3.4.  Em values for Cu-C112H/M121X azurin series and select variants, obtained through cyclic 
voltammetry. 
 
Azurin Variant Em (mV vs NHE) 
Wild Type 331 5 
M121G 401 5 
C112H/M121G 403 5 
C112H 398 5 
C112H/M121F 4175 
C112H/M121V 426 5 
 
Interestingly, slightly higher reduction potentials are observed for the hydrophobic 
axial variants C112H/M121F and C112H/M121V.  These data may suggest that desolvation 
and hydrophobicity effects described previously for the native azurin system are intact in 
these variants, albeit in a diluted form due to the mutation of cysteine.24, 25 It is clear that the 
electron transfer properties of the variant series are affected by the identity of the residue at 
the M121 position, despite the similar geometry of the Cu(II) forms displayed by UV-vis and 
EPR spectroscopy. 
 
 
3.3.4   Mutant-dependent scaffold modification observed after O2/ascorbate treatment 
 
As part of an investigation and systematic construction of the hydrogen atom 
abstraction process, we exposed the metallated proteins to reducing conditions (100 equiv. 
ascorbate) and a pure O2(g) atmosphere for 60 minutes at 25 C.  As shown in Figure 3.6, 
wild type azurin shows no oxidative modification to the scaffold when exposed to these 
oxidative stress conditions.  This was not surprising, as a previous report showed only 
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modest oxidative modification to this natural construct under similar conditions, and even 
with added peroxide26 
 
Figure 3.6. ESI-MS spectra of wild type azurin A) before and B) after treatment of the holo form 
(Cu(II) with 100 equiv. sodium ascorbate for 60 minutes.  
  
Shown in Figure 3.7 are the initial ESI-MS spectra of the Cu(II)-C112H/M121X 
azurin series. When the series was subject to ascorbate/O2 treatment, oxidative modification 
to the protein was observed via +16 Da modifications in the mass spectrum (Figure 3.8). 
These modifications were shown to require copper, ascorbate, and O2 treatment. 
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Figure 3.7. Electrospray mass spectra of Cu(II)C112H/M121X azurin series. The small peak in each 
case is a +16 Da oxidative modification.  
 
 
  
Figure 3.8. Electrospray mass spectra of A) C112H/M121G, B) C112H, C) C112H/M121V, and D) 
C112H/M121F variants after treatment of holo form (0.3 mM) with 100 eq. sodium ascorbate and 
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O2(g) for 60 minutes at 4 C. The unreacted population is marked in each case with an asterisk (*). 
All subsequent mass additions observed were incremental +16 Da additions. 
 
 
As mentioned, previous reports of oxidative modifications from metal-mediated 
reactive oxygen species has been reported in wild-type azurin,26 however it was evident that 
under our mild conditions, a clear pathway to ROS generation was available in the 
C112H/M121X series that was absent in wild-type azurin. Furthermore, as shown in Figure 
3.8, the extent of the modification to the scaffold was mutant dependent. The C112H 
mutation alone offered increased capacity for ROS modification over wild-type azurin, as 
only ~20% remained unmodified after the treatment. C112H/M121G azurin showed slightly 
less modification, while C112H/M121V and C112H/M121F azurin variant showed at least 8 
prominent oxidative modifications, leaving a negligible amount of protein unmodified 
(Figure 3.8.C and 3.8.D). 
 
The proteins were subject to demetallation and trypsin digest in an effort to determine 
the locations on the scaffold that were oxidatively modified.  As shown in Figure 3.9, the 
digestion pattern for each mutant in the series before treatment (dark colors) is identical (as 
expected) except for the fragment eluding from 70 minutes to 85 minutes, which was 
identified as the axial position 121 containing peptide. This peptide would have a mutant-
dependent elution time due to the variation in the 121 position. Multiple peaks in this region 
were identified as a missed cleavage product (+LK to amino terminus) and N-acetylated 
variants of the peptide of interest: 
 
 
 
In perfect agreement with the whole protein ESI-MS experiments, C112H and 
C112H/M121G azurins showed fewer changes in digestion pattern before and after treatment 
than the C112H/M121V and C112H/M121F azurins.  In all cases, a small amount of oxidation 
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at position Met-44 was observed (peak at 93 mins), but this has been previously reported as 
difficult to avoid during an efficient digest.26 C112H/M121V azurin showed oxidation of Met-
44, as well as significant modification to the peptide of interest, in a very similar fashion to 
C112H/M121F azurin. These data showed targeted protein oxidation, as other peptide 
fragments were largely unaffected by the treatment. 
 
Figure 3.9.  HPLC chromatograms for tryptic digests of the C112H/M121X series before (dark 
colors) and after (light colors) treatment with 100 equiv. sodium ascorbate for 60 mins under O2(g). 
 
3.3.5 A +16 Da modification to His-117 from C112H/M121F azurin 
 
It has proven difficult to identify the modified amino acids upon ascorbate/O2 
treatment of the Cu-C112H/M121X series, and this is presumably due the presence of 
multiple modifications on a single peptide unit. No theoretical peptides containing one, two, 
or three +16 Da units have thus far been identified, with one key exception.  Insight into one 
modification was gained by observing a change in solution color to yellow in the case of the 
C112H/M121F variant upon treatment with ascorbate/O2. This color persisted after 
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demetalation, and even after tryptic digest of the product peptide. UV-vis spectra of the 
reaction solution revealed a shoulder at 350 nm, characteristic of imidazole modification 
(Figure 3.10, top).27,  28 Indeed we observed a tandem MS/MS spectrum corresponding to a 
single +16 Da modification to His-117 (Figure 3.10, bottom), supporting formation of 2-oxo-
histidine.  We have not identified this modification in any other digest via computer mass 
search, but cannot rule out its existence in peptides containing multiple modifications. We 
have show the colored material is only obtained in the C112H/M121F variant (Figure 3.11 
left), and requires the presence of copper and an oxygen atmosphere for formation (Figure 
3.11 right). 
 
 
Figure 3.10.  (Top) Near UV-vis spectra of Cu(II)C112H/M121F azurin (0.2 mM) before  and after 
treatment with 100 equiv. sodium ascorbate in an O2(g) atmosphere. (Bottom) Tandem MS/MS 
spectrum of tryptic peptide ion [((pep)+ O +2H+))+2]containing a 2-oxo histidine modification. 
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Figure 3.11.  Monitoring the formation of yellow color at 315 nm. (Left) Kinetic mode UV-vis 
spectra upon addition of 100 equiv. sodium ascorbate to Cu(II)-proteins (0.2 mM) in an O2 
atmosphere. (Right) Control experiments using C112H/M121F performed under identical conditions, 
conducted with apo-protein or under a N2(g) atmosphere. Spectra were recorded at 25 C in 50 mM 
ammonium acetate, pH 6.4. 
 
 
Although oxidation of the imidazole group of histidine has been observed in proteins 
and peptides as a result of Fenton-Type copper/ascorbate/O2 chemistry,29,  30 the localization 
of the modification to the [104-122] peptide suggests copper-bound radical species such as 
Cu(II)OH or Cu(II)=O may be responsible for the observed modification.31 It is, however, 
clear that the C112H/M121X series shows the binding and reduction of dioxygen by copper 
ion in discrete active sites to form reactive oxygen species. 
  
3.4  Summary 
 
Mutation of the equatorial ligand cysteinyl residue in azurin to histidine resulted in 
transformation from a Type-1 copper site to a model Type-2 site; as evidenced by UV-vis 
and EPR spectroscopy.  A series of axial mutants (M121M, M121G, M121V, M121F) were 
engineered on the C112H template and showed markedly similar copper geometry.  A 
slightly lower energy d-d* band and similar EPR parameters to Cu2Zn2 SOD suggest that 
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water may be coordinated to the C112H/M121G variant, as has been shown in M121G azurin 
(See Chapter 1). Thus, this variant in particular is a good structural model of the electron 
transfer site of PHM and DM enzymes. 
Despite the similar geometry around the copper ion the mutant series exhibited 
markedly different reactivity when treated with excess reductant (ascorbic acid) under an 
oxygen atmosphere.  In stark contrast to wild type azurin, all C112H mutants exhibited 
scaffold modification upon treatment (as evidenced by incremental +16 Da additions in the 
ESI mass spectrum) with the C112H/M121V and C112H/M121F variants showing extensive 
scaffold modification.  Trypsin digest of the reaction mixture, followed by HPLC separation 
and tandem ESI MS/MS analysis showed that oxidative modification to the proteins was 
largely isolated to the peptide fragment containing copper-ligating His-117 and His-112, and 
potentially the axial target at position 121. 
A yellow color generated in the C112H/M121F variants during the course of the 
reaction was identified as a modification on the His-117 residue, as determined by ESI-
MS/MS analysis. This modification required the presence of copper, O2, and excess 
ascorbate for formation. These results suggest that mutation of Cys-112 to His in azurin 
facilitates the binding and reduction of dioxygen to superoxide and/or further reduction 
products, and oxygen insertion into proteinic amino acids.  Localization of the modification 
to a tryptic peptide containing two of the three copper ligands and the engineered 
intramolecular substrate support copper-generated ROS species as the source of the observed 
modification. In lieu of the spectroscopic (as determined by UV-vis and EPR) and 
electrochemical (as determined by cyclic voltammetry) similarities of the copper sites in the 
C112H/M121X series, differences in reactivity with O2 may be rationalized in terms of 
oxygen accessibility to copper center in the protein scaffold.  Indeed it was shown in Chapter 
2 and in prior literature18,  32,  33 that mutation of axial Met-121 to the small and non-
coordinating Gly resulted in increased small-molecule access. 
Although many steps have been taken towards the goal of biomimetic C-H bond 
hydroxylation, and despite poising of an abstractable hydrogen atom in vicinity to any 
generated copper-ligated ROS, we have yet to identify any C-H insertion products.  Clarity 
will be gained when the experiment is repeated in the presence of isotopically labeled 
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18O2(g). Comparison of tryptic digest traces between 16O2 and 18O2 will reveal O2-insertion 
products, in analogy to techniques described in Chapter 2. 
 
3.5      References 
 
(1) Champloy, F.; Benali-Cherif, N.; Bruno, P.; Blain, I.; Pierrot, M.; Reglier, M.; 
Michalowicz, A. Inorg. Chem. 1998, 37, 3910-3918.  
(2) Siebert, X.; Eipper, B. A.; Mains, R. E.; Prigge, S. T.; Blackburn, N. J.; Amzel, L. M. 
Biophys. J. 2005, 89, 3312-3319.  
(3) Jacob, C.; Giles, G. I.; Giles, N. M.; Sies, H. Angew. Chem. , Int. Ed. 2003, 42, 4742-
4758.  
(4) Prigge, S. T.; Eipper, B. A.; Mains, R. E.; Amzel, L. M. Science 2004, 304, 864-867.  
(5) Rolff, M.; Tuczek, F. Angew. Chem. , Int. Ed. 2008, 47, 2344-2347.  
(6) Snipes, W.; Schmidt, J. Radiat. Res. 1966, 29, 194-202.  
(7) Davies, K. J.; Delsignore, M. E.; Lin, S. W. J. Biol. Chem. 1987, 262, 9902-9907.  
(8) Burgess, V. A.; Easton, C. J.; Hay, M. P. J. Am. Chem. Soc. 1989, 111, 1047-1052.  
(9) Croft, A. K.; Easton, C. J.; Radom, L. J. Am. Chem. Soc. 2003, 125, 4119-4124.  
(10) Den Blaauwen, T.; Van, d. K.; Canters, G. W. J. Am. Chem. Soc. 1991, 113, 5050-5052.  
(11) Nilges, M. J. Ph.D. Thesis, University of Illinois 1979. 
(12) Chang, H. R.; Diril, H.; Nilges, M. J.; Zhang, X.; Potenza, J. A.; Schugar, H. J.; 
Hendrickson, D. N.; Isied, S. S. J. Am. Chem. Soc. 1988, 110, 625-627.  
(13) Humphrey, W.; Dalke, A.; Schulten, K. J. Mol. Graph. 1996, 14, 33-38.  
(14) MacPherson, I.; Murphy, M. Cell. Mol. Life Sci. 2007, 64, 2887-2899.  
(15) Malmström, B. G. Eur. J. Biochem. 1994, 223, 711-718.  
(16) Solomon, E. I.; Penfield, K. W.; Gewirth, A. A.; Lowery, M. D.; Shadle, S. E.; Guckert, 
J. A.; LaCroix, L. B. Inorg. Chim. Acta 1996, 243, 67-78.  
   
 
80 
 
(17) Pierloot, K.; De Kerpel, J. O. A.; Ryde, U.; Roos, B. O. J. Am. Chem. Soc. 1997, 119, 
218-226.  
(18) Di Bilio, A. J.; Chang, T. K.; Malmström, B. G.; Gray, H. B.; Karlsson, B. G.; Nordling, 
M.; Pascher, T.; Lundberg, L. G. Inorg. Chim. Acta 1992, 198-200, 145-148.  
(19) Ferreira, A. M. D. C.; Santos, M. L. P. D.; Pereira, E. M.; Damasceno, M. O.; Alves, W. 
A. An. Acad. Bras. Cienc. 2000, 72, 51-58.  
(20) Han, J.; Loehr, T. M.; Lu, Y.; Valentine, J. S.; Averill, B. A.; Sanders-Loehr, J. J. Am. 
Chem. Soc. 1993, 115, 4256-4263.  
(21) den Blaauwen, T.; Hoitink, C. W. G.; Canters, G. W.; Han, J.; Loehr, T. M.; Sanders-
Loehr, J. Biochemistry (N. Y. ) 1993, 32, 12455-12464.  
(22) Lu, Y.; Roe, J. A.; Bender, C. J.; Peisach, J.; Banci, L.; Bertini, I.; Gralla, E. B.; 
Valentine, J. S. Inorg. Chem. 1996, 35, 1692-1700.  
(23) Müller, J.; Felix, K.; Maichle, C.; Lengfelder, E.; Strähle, J.; Weser, U. Inorg. Chim. 
Acta 1995, 233, 11-19.  
(24) Garner, D. K.; Vaughan, M. D.; Hwang, H. J.; Savelieff, M. G.; Berry, S. M.; Honek, J. 
F.; Lu, Y. J. Am. Chem. Soc. 2006, 128, 15608-15617.  
(25) Marshall, N. M.; Garner, D. K.; Wilson, T. D.; Gao, Y.; Robinson, H.; Nilges, M. J.; 
Lu, Y. Nature 2009, 462, 113-116.  
(26) Lim, J.; Vachet, R. W. Anal. Chem. 2003, 75, 1164-1172.  
(27) Kowalik-Jankowska, T.; Rajewska, A.; Jankowska, E.; Wisniewska, K.; Grzonka, Z. J. 
Inorg. Biochem. 2006, 100, 1623-1631.  
(28) Mason, B.; McCracken, M.; Bures, E.; Kerwin, B. Pharm. Res. 2010, 27, 447-456.  
(29) Uchida, K.; Kawakishi, S. Biochem. Biophys. Res. Commun. 1986, 138, 659-665.  
(30) Uchida, K.; Kawakishi, S. Bioorg. Chem. 1989, 17, 330-343.  
(31) Uchida, K.; Kawakishi, S. J. Biol. Chem. 1994, 269, 2405-2410.  
(32) Vidakovic, M.; Germanas, J. P. Angew. Chem., Int. Ed. 1995, 34, 1622-1624.  
(33) Fraczkiewicz, G.; Bonander, N.; Czernuszewicz, R. S. J. Raman Spectrosc. 1998, 29, 
983-995.  
 
   
 
81 
 
  
   
 
82 
 
Chapter 4. Engineering a rhodium acetate cofactor into CRABP-II: 
towards NO sensing and catalysis in water 
 
4.1  Introduction 
 
4.1.1    Scaffolding rhodium acetate for carbene transfer in water 
 
Carbenoids generated from diazo compounds have been established as highly 
efficient means for formation of C-C or C-H bonds with high chemo- and stereoselectivity.1, 2 
Insertions of carbene units into unsaturated substrates is an effective means to synthesize a 
variety of functional groups including cyclopropanes3 and azidirines,4 with otherwise difficult 
to control stereochemistry.  Stereochemical control of such transformations is essential for 
production of a number of important compounds, including biologically relevant drugs and 
natural products.5 The stereochemistry of products resulting from carbene insertion reactions 
depends in part on the nature of the substrate and the presence of nearby functional groups 
and electron density.  However, it has been shown that the ligand environment around the 
active metal center in carbene transfer reactions is essential for the control of substrate access 
and orientation, and, as a result, the stereochemical character of the resulting product.1, 6  For 
example, it has been reported that the incorporation of rhodium acetate dimer into a 
calixarene scaffold leads to greatly enhanced oxidative amination of C-H bonds in 
comparison to most bare catalysts of the form Rh2(X)4.7 Similar successes have been reported 
with chirality inducing ligands such as adamantylglycine.6   
Typically, carbene insertion reactionsare carried out in the absence of water, due to 
competing insertion of the active carbene unit into the O-H bond of water.8 Rhodium acetate-
hosted carbene transfer in water have been reported, but avoidance of the formation of the 
water O-H insertion product has required hydrophobic substrates,8 or assembly of 
supramolecular catalyst/substrate ‘beads’ in solution.3 To this end, a tunable protein scaffold 
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turn-on response was only 2.2-fold over the baseline, and this was cited as due to poor 
loading efficiency and aqueous degredation of the initial complex. In collaboration with the 
Lippard group, we sought to improve on this design, through discreet protection of rhodium 
acetate-fluorophore conjugates with protein monomers.  
 
4.1.3 Interaction of rhodium acetate with proteins and peptides 
 
The study of rhodium acetate with biological materials (proteins and DNA) has 
received interests due to preliminary reports of antitumoral activity of this and related heavy 
metal compounds. 19‐21 Rhodium acetate dimer has previously been incorporated into human 
serum albumin (HSA)22‐24 as well as into cytochrome c,25 with target applications in anti-
cancer drug delivery and the probing of the mechanism of chemotherapeudic activity of this 
and similar heavy metal complexes.  In the case of HSA, rhodium acetate was found to 
exclusively bind to histidine residue, but due to the large amount of histidine residues 
protein, multiple sites were occupied by rhodium acetate, and characterization of metal 
binding and the resulting protein fold was not extensive.22‐24  Incorporation into cytochrome c 
resulted in the formation of [protein-Rh2(OAc)4-protein] dimers through surface exposed 
histidine residues, which did not significantly affect the EPR behavior, nor the reduction 
potential of the iron centers contained in the heme groups of cytochrome c.25 However, 
specific incorporation of a single rhodium acetate unit, while maintaining an open metal 
binding site for the purposes of small molecule processing, has not thus far been reported.   
 
4.1.4 Previous engineering efforts using the CRABP-II 
 
Cellular retinoic acid binding protein (CRABP-II) was selected as an ideal protein 
scaffold as a result of several considerations including size, shape, and recombinant 
expression in E. coli.  This family of proteins possesses an attractive hydrophobic cavity of 
300-500 A3 in size,26 and can best be described as a hydrophobic bowl. Interestingly, the 
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CRABP-II scaffold exhibits no native histidine residues, which we envisaged could be 
engineered into the scaffold via site directed mutagenesis as highly selective rhodium binding 
sites. This approach is not novel in principle. In 1998, adipocyte lipid binding protein 
(ALBP), a sister scaffold, was used to selectively tether two catalyst ligands (a 
phenanthroline catalyst- towards amide and ester bond hydrolysis, and a pyridoxamine 
catalyst- towards transamination) via conjugation to an engineered cysteinyl residue.26 Later, 
a similar report cited intestinal fatty acid binding protein (IFABP) as a scaffold for a 
pyridoxamine catalyst for transamination of -keto acids; and reported a 94% ee with some 
substrates.27 In a noteworthy engineering feat, the CRABP-II scaffold has itself been 
rationally reengineered to change the binding partner from retinoic acid to retinal through 
manipulation of conserved barrel amino-acids,28 mimicking the carrier protein, rhodopsin. 
These successes poised the CRABP-II scaffold as promising in the hosting of carbene-
transfer chemistry and NO sensing in water. 
We have demonstrated initial success in engineering a rhodium acetate-selective 
binding site in the CRABP-II scaffold through engineering of accessible histidinyl residues.  
The variants investigated show promise in protein-hosted nitric oxide sensing. The large 
hydrophobic pocket and high stability of the CRABP-II fold ensure that the scaffold will find 
utility in further modeling efforts. 
 
4.2 Experimental 
 
4.2.1   Mutagenesis and protein preparation 
 
CRABP-II has been recombinantly expressed in e-coli.29,  30 The CRABP-II gene on 
pET-17b vector was generously donated by Dr. Honggao Yan from the Department of 
Biochemistry at Michigan State University. The gene arrived in an envelope; adsorbed onto a 
piece of filter paper protected by a plastic bag. The section of paper containing the plasmid 
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DNA was cut out and soaked in 100 L TE buffer (10 mM Tris·HCl, 1 mM EDTA, pH 8.0) 
for 20 mins, and 2 L of the resulting solution was transformed into 50 L competent XL1-
Blue cells. The resulting solution was plated onto an LB agar plate in the presence of 50 
mg/mL ampicillin and incubated overnight. A colony of the transformed cells was 
miniprepped to yield 50 L of 100 ng/L plasmid solution.  
DNA sequencing of the plasmid revealed a deleted cytosine base at nucleotide 
position 501 from the start ATG codon, resulting in a frame shift mutation. A primer set was 
designed to reinsert the deleted cytosine base: 
                          
  Fwd - 5’-GTG TGC ACC AGG GTC TAC GTC CGA G-3’ 
Rev - 5’-CTC GGA CGT AGA CCC TGG TGC ACA C-3’ 
 
PCR (see Chapter 1) was performed on 1 L of 1 ng/L frameshifted plasmid in the 
presence of the above primers, and the resulting DNA solution was transformed into XL1-
Blue cells and miniprepped. DNA sequence results indicated successful reinsertion of the 
deleted base. 
Mutations were prepared on the template plasmid (pet17b vector) using the 
Quickchange site-directed mutagenesis method.  The primers used were M93H: fwd-5’-
AGT-GAG-AAT-AAA-CAT-GTC-TGT-GAG-CAG-3’,  R111H: fwd-5’-ACC-TCG-TGG 
ACC-CAT-GAA-CTG-ACC-3’, I52H: fwd-5’-GAC-ACT-TTC-TAC-CAT-AAA-ACC-
TCC-ACC-3’, L121H: fwd-5’-GGG-GAA-CTG-ATC-CAT-ACC-ATG-ACG-3’, T54H: 
fwd-5’-TTC-TAC-ATC-AAA-CAT-TCC-ACC-ACC-3’,  F15H:  fwd-5’-CGA-TCG-GAA 
AAC-CAT-GAG-GAA-TTG-3’, along with the reverse complement backward primer. The 
Cys-removal primers used were: C81S: fwd-5’-GGG-AGG-CCC-TCC-AAG-AGC-CTG-
GTG-3’, C95S: fwd-5’-AAA-ATG-GTC-TCC-GAG-CAG-AAG-CTC-3’, and C130S: fwd-
5’-GAC-GTT-GTG-TCC-ACC-AGG-GTT-TAC-3’, along with the reverse complements 
backward primer. Mutations were confirmed by plasmid sequencing at the DNA Sequencing 
Laboratory at the University of Illinois using a T-7 promoter target.  Proteins were prepared 
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according to the CRABP-II purification procedure below, and mutants were identified via 
ESI mass spectroscopy. 
CRABP-II protein expression: 
The gene to be expressed was transformed into BLR-DE3 cells for protein 
expression. To 5 mL of LB solution was added 5 L ampicillin (50 mg/mL) and a single 
colony of BLR-DE3 cells containing the desired gene.  The solution was shaken for 6 hrs at 
37C, and 1 mL aliquots of the resulting solution were added to 2 L sterile preparations of 
2xYT media, each containing 1 mL of ampicillin (50 mg/mL).  A typically expression was 
conducted with 8 L media.  The solutions were stirred at 25 C for 14 hrs, and the cells were 
collected via ultracentrifucation at 9000 rpm.  The cells were resuspended in 100 mL lysis 
buffer (10 mM Tris·HCl, pH 8.0, 1 mM EDTA, 0.1% Tritonx100, 1 mM PMSF, 25 mg 
RNAse, 25 mg DNAse) via shaking at 4 C for 30 mins.  The resulting suspension was lysed 
via French Press at 1500 psi (2x passes), and the insoluble fraction was separated via 
ultracentrifugation at 15000 rpm for 45 mins.  
CRABP-II protein purification: 
Wild type and T54H CRABP-II was found in the soluble fraction of the lysed 
suspension and was purified as follows accord into a slightly modified procedure:31 To the 
soluble fraction was added equal volumes of 10 mM Tris·HCl, pH 8.0 and Millipore water, 
until the conductivity matched that of 10 mM Tris·HCl, 8.0 (about 1 L total volume).  To the 
resulting solution was added ~100 mL SP-Sepharose beads (pre-equilibrated with 10 mM 
Tris·HCl, pH 8.0) with stirring. After 30 mins, the beads were allowed to settle, and were 
gathered and loaded onto a Sepharose column. The protein was eluded from the column 
using a Gradifrac system, and was eluded with a linear gradient of NaCl from 0 to 500 mM. 
CRABP-II variants that expressed into inclusion bodies (eg, I52H) were found in the 
insoluble fraction of the lysed solution, and were refolded and purified as follows: The 
insoluble pellets were first washed with 100 mL of Millipore water and centrifuged at 15000 
rpm for 10 minutes and the supernatant was discarded. To this solution was added 5M 
Gd·HCl and the suspension was shaken at 4 C for 90 mins. After centrifugation at 15000 
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rpm for 20 minutes, the resulting soluble fraction was slowly added to 1 L refolding buffer 
(10 mM Tris·HCl, pH 8.0, 10 mM DTT) at 4 C dropwise over 15 minutes.  The resulting 
solution was centrifuged again, and the supernatant was added to a dialysis bag (8000 
MWCO) and dialyzed against 4L 10 mM Tris·HCl, pH 8.0 (4x 12 hours exchanges).  The 
resulting solution was centrifuged, and to the resulting supernatant was added pre-
equilibrated SP-Sepharose beads, and the purification was carried out as above.   
Collected fractions were subjected to SDS-PAGE analysis, and those fractions 
containing the desired protein were pooled and concentrated via Amicon membrane (10000 
MWCO).  The protein solution was then purified further by passing down a 100 cm gel 
filtration column (GE Healthcare) containing Sephacryl S-100 high resolution media 
equilibrated with 10 mM Tris·HCl, pH 8.0 at a rate of 0.5 mL/min to yield the desired 
protein in high purity. 
  
4.2.2 Spectroscopic measurements 
 
UV-Vis spectroscopy was performed on either an HP Agilent 8453 Diode Array 
Spectrometer or a Cary 5000 Spectrometer. ESI mass spectroscopy was performed on a 
Waters Quattro 2 mass spectrometer at the Mass Spectroscopy Laboratory of UIUC.  
Circular dichroism was performed on a Jasco J-715 spectropolarimeter with a temperature 
controller set at 20C and a path length of 1.0 cm. 
 
4.2.3 NO detection measurements 
 
Protein samples for nitric oxide (NO) detection were frozen in liquid nitrogen and 
sent to the Lippard group at MIT for complex conjugation and NO experiments. 
Investigations were carried out by Joel Rosenthal, a postdoctoral student in the Lippard 
Group. NO manipulations are transcribed here verbatim from ref. 17: Nitric oxide gas was 
purified following a reported procedure involving sequential passage through an Ascarite 
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column and a 6 ft silica gel coil at -78°C. Manipulation of purified NO(g) was performed 
under an atmosphere of dry nitrogen using standard gas storage bulbs and gas-tight syringes. 
UV-vis spectra were recorded on a Cary IE scanning spectrophotometer. Fluorescence 
spectra were acquired anaerobically using a Photon Technology International Quanta Master 
4L scanning spectrofluorimeter held at a constant temperature of 22° C by use of a 
circulating watercooled cuvette holder. Samples for fluorescence had a pathlength of 1 cm in 
Spectrosil quartz cuvettes, with optical density of < 0.06 and volumes of 3 mL. 
 
4.2.4 Elemental analysis measurements 
 
ICP-OES analysis was performed at the University of Illinois Microanalysis 
Laboratory using a Perkin Elmer – SCIEX ELAN DRCe ICP-MS instrument with OES 
capabilities. Solutions of protein (4.0 mL 1-2 mM in 20 mM Tris·HCl buffer) were submitted 
for analysis along with a blank solution containing no protein.  The calibrations were built 
using rhodium and sulfur standard solutions of 60 ppm.  
 
4.3 Results and discussion 
 
4.3.1  Designing a His variant series form rhodium acetate docking 
 
As native CRABP-II exhibits no histidine residues, and axial N-ligated carbene 
chemistry has been previously reported in immobilized systems,32, 33 we designed single His 
point mutations in the CRABP-II as a strategy for controlled axial docking of the complex 
within the cavity of the -barrel (envisioning the other axial site would be available for small 
molecule docking and processing).  Shown in Figure 4.2 is the crystal structure of wild-type 
CRABP-II in complex with natural binding partner, all-trans retinoic acid.  As can be seen in 
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the ribbon diagram, the fatty acid fits into a cleft created by a beta barrel motif and an -
helix-containing ‘lid’ strand. 
 
  
 
Figure 4.2 (Left) Ribbon diagram of crystal structure of wild-type CRABP-II in complex with all-
trans retinoic acid (PDB code: 2FR3 (ref. 34). (Right) Amino acids chosen for mutant to His, 
sampling various locations within the cavity structure. 
 
 
Several amino acid locations were selected for mutation to histidine residues, 
spanning various depths into the cavity and various degrees solvent accessibility in the 
CRABP-II scaffold.  While DNA plasmids for the entire series were prepared, we selected 
the T54H mutant for initial studies due to its location in the upper rim of the barrel cavity.   
 
4.3.2 Structure of the T54H CRABP-II variant 
 
The T54H CRABP-II variant was express and purified according to established 
methods. Shown in Figure 4.3 are the mass spectra of wild type CRABP-II and T54H-
CRABP-II, showing successful incorporation of the engineered histidine residue.   
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Figure 4.3 ESI-MS spectra of purified (left) wild type CRABP-II (calc: 15567 Da) and (right) T54H-
CRABP-II (Calc: 15604 Da) 
 
Crystals of T54H-CRABP-II were grown at 25 C via vapor diffusion according to a 
previously published protocol,35 and the crystal structure was collected at 1.84 Å resolution. 
As shown in the ribbon diagram representation in Figure 4.3, a nearly perfect overlay with 
wild-type protein is obtained in this variant.  In fact, the methylene carbon atom of the 
engineered histidinyl residue overlays perfectly with the -carbon of the original threonine 
group, while the extra atoms protrude into the cavity space. These results were encouraging 
and supported investigation into the mutant for rhodium acetate binding. 
 
  
 
Figure 4.4. Side (left) and top (right) view of ribbon diagram overlays of wild type (yellow) (PDB 
code (ref. 34) and T54H (blue) CRABP-II crystal structures. 
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4.3.3 Initial binding studies of rhodium acetate to T54H-CRABP-II 
 
The T54H-CRABP-II variant, along with wild type CRABP-II were treated with an 
excess (20 equiv.) of rhodium acetate in 10 mM Tris·HCl, pH 8.00 at 4 C.  After stirring for 
2 hours, the solutions were purified via size exclusion chromatography to remove the excess 
rhodium complex.  The T54H variant solution had a yellow color, while the wild type protein 
remained colorless after purification. Solutions of the complexes (2.0 mL of 1.0 mM) were 
submitted for elemental analysis via tandem ICP/OES analysis for a simultaneous 
determination of rhodium and sulfur content.  As protein was the only sulfur source in the 
solution, and each molecule of CRABP-II contains 6 sulfur atoms, this technique offered a 
direct determination of metal:protein ratio. As shown in Table 4.1, the engineered T54H 
mutation resulted in the binding of two rhodium atoms per protein unit, while the wile type 
protein showed little to no retention of rhodium after size exclusion chromatography. 
 
Table 4.1. Results of ICP-OES analysis for rhodium acetate treated solutions of CRABP-II. Solutions 
of CRABP-II (0.2 mM) were treated with 20 equiv. rhodium acetate at 4 C for 4 hours, followed by 
size exclusion chromatography. Results are an average of three measurements for a single sample. 
Sample Rh 
(ppm)
S 
(ppm)
Rh:S(ppm) Rh:protein(mol)
Wild Type + 20 equiv. Rh2OAc4 0.03 18.6 0.002 0.002 
T54H + 20 equiv. Rh2OAc4 16.9 12.9 1.28 1.97 
 
 
Circular dichroism (CD) spectra allowed for determinations of structural 
perturbations to the protein upon interaction with rhodium actetate.  As shown in Figure 4.6, 
the CD spectrum of wild type CRABP-II exhibits a typical -barrel motif.36  The spectrum is 
relatively unchanged upon treatment with 20 equiv. rhodium acetate and size-exclusion 
chromatography, while that of T54H shows markedly different CD spectrum.  In the latter 
case, conversion of -barrel structure random coil structure is evidence by an increase in 
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signal at 208 nm, and a decrease in signal at 218 and 235 nm.37 These data corroborate 
elemental analysis results, and demonstrate selective interaction of rhodium acetate with the 
engineered His-containing variant. Structural perturbations may be the result of scaffold 
rearrangement in order to accommodate the incoming cofactor. 
 
 
Figure 4.5. (Left) Circular dichroism spectra of wild type (left) and T54H (right) azurins upon 
treatment with 20 equiv. Rh2OAc4 at 4 C for 4 hours and size exclusion chromatography via PD-10 
column. Spectra were acquired in 1.00 mL solutions of 5 M protein in 10 mM potassium phosphate 
buffer, pH 8.0. 
 
4.3.4 Towards NO detection within the CRABP-II scaffold 
 
The T54H-CRABP-II variant was investigated for hosting a rhodium acetate nitric 
oxide sensor in entirely aqueous solution. These studies were carried out at MIT in the 
Lippard Laboratory by postdoctoral student, Joel Rosenthal. The same amine tethered 
fluorophores were used as with the polymer system:18 dansyl-piperidine (secondary amine) 
and dansyl-ethylene diamine (primary amine) (Figure 4.4) 
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Figure 4.6. Lewis structures of amine-ligated fluorophores used in this study 
 
The response of the dansyl-pip and the rhodium acetate dimer to NO in buffer was 
first measured as a control. As shown in Figure 4.5.A, the emission intensity of the Rh2OAc4-
dansyl-pip complex does not increase upon exposure to 500 equivalents NO. A slow loss of 
emission intensity over 45 minutes was indicative of complex degradation. Remarkably, an 
increase in emission intensity is observed in the presence of a slight excess of T54H-
CRABP-II protein (1.5 equiv.) (Figure 4.5.B); maximizing in a 70% increase after two 
minutes. The dansyl-EDA complex exhibited similar results (data not shown). These results, 
although preliminary, show a clear proof of concept in fluorophore release from a Rh2OAc4-
T54H-CRABP-II construct. 
 
Figure 4.7. Emission spectrum of a solution of Rh2(OAc)4-dansyl piperidine (0.067 mM) in 10 mM 
Tris·HCl, pH 8.5 upon treatment with 500 equiv. NO over 45 minutes in the (A) absence and (B) 
presence  of 0.1 mM (1.5 equivalents) T54H-CRABP-II. 
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Since these studies, we have shown in the Lu laboratory that the rhodium acetate 
construct is slowly degraded in Tris·HCl buffer, as evidenced by a loss of UV-vis spectral 
signals.  This may explain in part the slow degradation of the fluorophore-Rh2OAc4-T54H 
CRABP-II construct observed in the NO experiments, although the experiment was not 
performed in the absence of NO as a control to address this. Since these studies, further 
rhodium acetate-protein chemistry has been carried out in 10 mM potassium phosphate 
buffer, at pH 8.0. 
 
4.3.5 Design of a Cys-free CRABP-II scaffold for thiol-conjugation studies 
 
The human CRABP-II protein used in these studies has three native cysteinyl 
residues, none of which participate in structural or functional disulfide bonding.  We 
reasoned that replacement of native Cys residues with the isostructural Ser residue would 
result in a His- and Cys-free beta-barrel scaffold, maximizing versatility for bioconjugation.  
To this end, we prepared ‘3xSer’ CRABP-II (C81S/C95S/C130S), (also called Cys-KO-
CRABP-II). Initial attempts at expression and isolation showed this mutant expressed into 
inclusion bodies and refolding has been unsuccessful. Efforts to develop an efficient 
refolding protocol are underway. 
 
4.4 Summary 
 
In summary, the CRABP-II scaffold has been made accessible as a general scaffold to 
the Lu group; through correction of a frame shift mutation in a received DNA plasmid and 
the development of a general refolding protocol for mutants expressed in inclusion bodies. 
This beta-barrel scaffold, exhibiting a large hydrophobic cavity, will no doubt find utility in 
future protein design efforts in the Lu group. A series of single His variants were prepared in 
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the context of a selective binding site for rhodium acetate complex, with target applications 
in asymmetric carbene transfer catalysis and NO sensing applications. 
We have engineered a rhodium acetate-CRABP-II construct through engineering a 
CRABP-II variant (T54H) exhibiting a single histidine imidazole ring. Circular dichroism 
experiments revealed a rhodium acetate induced folding change in T54H CRABP-II that is 
absent in wild-type CRABP-II, suggesting selective binding to the T54H CRABP-II scaffold. 
The engineered protein-rhodium acetate construct showed promise in aqueous NO detection 
through ejection of a metal-bound fluorophore with added NO. 
In 2009, the Ball group released a paper outlining the incorporation of the dirhodium 
acetate scaffold into a series of designed peptides containing two aspartate ligands for 
carboxylate exchange.38  The peptide-rhodium acetate conjugates were prepared in an elegant 
fashion by exploiting the lability of fluorinated bridging acetate groups. Thus, the 
Rh2(OAc)2(-OOCCF3)2 complex enchanged into well designed 2-carboxylate-containing 
peptides under mild conditions. In 2010, similar constructs were used to demonstrate 
prototypical carbene transfer into S-H bonds.39 The Ball group also used this approach in the 
synthesis of selective tryptophan modifying bio-catalysts employing peptide hosted rhodium 
acetate.40 However, it can be argued that a solvent exposed histidine would be less ubiquitous 
than carboxylate ligands when engineering binding sites into natural scaffolds. Nevertheless, 
anchoring through the bridging ligands on the lantern-type rhodium acetate scaffold makes 
available both metal atoms for catalysis, and is therefore a superior approach with respect to 
designing of aqueous scaffold for the carbene chemistry described herein. 
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Chapter 5. Development of a Temperature Independent pH (TIP) Buffer 
for Applications at Cryotemperature 
Portions of this chapter have been accepted for publication in Chem. Comm. (ref. 1 ) 
 
5.1      Introduction 
 
5.1.1  A temperature independent pH (TIP) buffer 
 
Storage and analysis of samples at low temperatures has become a routine practice in 
modern research, as storage at low and cryogenic temperatures can preserve integrity of 
precious samples, and biophysical and bioanalytical techniques performed under these 
temperatures have provided information on biomolecules at an unprecedented level.2‐6 Many 
branches of the biological community, including drug storage, food storage, cell physiology, 
spectroscopy and X-ray crystallography, have a vested interest in low temperature effects on 
a pH buffered system. It is widely known that the pH of a buffer solution can change at low 
temperatures, which could dramatically affect the properties of molecules of interests.  This 
effect has been ascribed to enthalpic effects on the proton equilibrium as well as selective 
precipitation of buffer components upon cooling.7 Developing buffer systems that display 
temperature independent pH characteristics could prevent erroneous conclusions about 
molecular structures and dynamics at the physiological temperature.  
We have now addressed this long standing problem by combining buffers exhibiting 
an increase in pH upon freezing with those exhibiting a decrease. To demonstrate the utility 
of these Temperature-Independent-pH (TIP) buffers, we show that such a buffer can help to 
preserve the integrity upon freezing of pH-sensitive pharmaceutical drugs, such as the -
lactam containing antibiotic oxacillin, while other buffers fail. Low temperature, pH-
dependent UV-vis and EPR studies of human methemoglobin (met-Hb) in the presence of 
TIP buffers yielded spectra intermittent between those in potassium phosphate or HEPES 
buffer alone, demonstrating that the pH changes less in the TIP buffer upon freezing. The 
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method described here for the temperature independent buffer can be generally applied to 
other buffer systems at a different pH value. 
 
5.1.2 Measuring pH at low temperatures 
 
Low temperature effects on the pH of a buffered system have been known for a long 
time. About 75 years ago, Finn and coworkers reported the denaturation of proteins 
contained in muscle juice due to the variation in hydrogen ion and salt concentrations upon 
freezing.8 Thereafter, activity loss of aldolase, phosphofructokinase and several 
dehydrogenases in sodium and potassium phosphate buffer at lower temperatures has been 
observed and ascribed to pH effects.7,  9,  10 Several strategies have been applied to measure 
temperature-dependent pH characteristics, such as the measurement of electromotive force 
(emf) to determine temperature dependence of pKa values, or the use of pH-sensitive dyes to 
probe protonic activity at low temperatures.11‐14 It was reported that EPR (electron 
paramagneticresonance) based estimates of the apparent pH change from the observation of 
several pH-sensitive systems (such as the flavin adenine dinucleotide semiquinone radical 
(FADH) in xanthine oxidase) coincide well with estimates based onindicator dye optical 
changes.13  
Despite broad awareness, and extensive research into the relevance and merits of 
cryotemperature studies on biological systems (made salient by the prominent journals 
CryoLetters and Cryobiology), no reports of strategies to obtain buffers that resist 
temperature-dependent pH changes have appeared in the literature. Here we address this long 
standing problem through combination of buffers exhibiting an increase in pH upon freezing 
with those exhibiting a decrease. The utility of these temperature-independent-pH (TIP) 
buffers in preserving the sample integrity upon freezing of pH-sensitive pharmaceutical 
drugs, and in spectroscopic studies of human methemoglobin(met-Hb) is also demonstrated. 
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5.2 Experimental  
5.2.1 Preparation of buffer solutions 
 
All buffers and reagents were purchased either from Aldrich or Fisher 
Scientific.Bromothymol Blue (BTB) (Fisher Scientific) and Bromocresol Green (BCG) 
(Acros, New Jersey) were used without further purification. Dipotassium hydrogenphosphate 
(Fisher Scientific), Monopotassium hydrogenphosphate (Fisher Scientific), MOPS (3-N-
morpholino propansulfonic acid) (Fisher Scientific), sodium acetate (Fisher Scientific), Tris 
(2-Amino-2-(hydroxymethyl)-1,3-propanediol) (Fisher Scientific), HEPES ((4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid) (Fisher Scientific), and MES (2-(N-
morpholino)ethanesulfonic acid) (Fisher Scientific) were also used as purchased.  Indicator 
solution was prepared with 0.075% (w/w) BTB, 0.075% (w/w) BCG in 70% 2-propanol and 
30% water mixture. 
 
5.2.2 Low temperature UV-vis spectroscopy 
 
In order to measure UV-vis spectra at low temperature, a Cary 3E UV-vis (Varian, 
Palo Alto, CA) spectrometer was modified with a transparent double-Dewar system. The 
transparent disposable cuvette (Fisher Scientific) with path length 4.3 mm was inserted and 
stabilized in the inner Dewar.  The thermometer rod was attached at the corner of the cuvette 
in order to measure the temperature of cuvette directly.  In order to control the temperature, 
liquid N2 was poured through a plastic funnel, which is connected to the Dewar with a long 
and thin tube. To avoid condensation outside of the Dewar, a fast stream of nitrogen was 
blown over the Dewar throughout the experiments.  The control of temperature was achieved 
by the amount of liquid N2 in the Dewar and the temperature was monitored with a digital 
thermometer (Digi-sense, Cole Parmer).  The pH measurements at room temperature were 
made using an Accumet AB15 (Fisher Scientific) pH meter.  
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5.2.3 Preparation of calibration curves for Ratio A420/A620 versus pH 
 
Quantification of apparent pH change was accomplished via development of a room 
temperature calibration curve correlating absorption peak maxima ratios to pH, and 
subsequent correlation of low temperature absorption spectra to apparent pH. Absorption 
ratios measured as A420/A620 (x) were correlated to apparent pH (y) using the equation 
generated for each buffer or buffer combination over the desired pH range at room 
temperature. These equations are relevant for 0.1 v/v% BCG:BTB dye and 50 mM buffer in 
75 v/v% glycerol at a path length of 4.3 mm.  Data obtained upon decrease in temperature 
was correlated to apparent pH change through these equations. 
 
5.2.4 Preparation of human hemoglobin solution 
 
Lyophilized human hemoglobin (Aldrich) was dissolved in 50 mM buffer solutions 
and centrifuged at 13 x103 rpm to separate undissolved protein.  The supernatant was then 
oxidized by treatmentwith 0.9 equiv K3Fe(CN)6 for 10 minutes on ice with stirring. The 
protein was then purified by passing the solution down a PD-10 column (GE Healthcare).  
Eluted protein was then concentrated using a microcentrifuge membrane (10,000 MWCO, 
Amicon) and stored at 4 C until experimentation.  The molar extinction coefficient of the 
Soret transition at 405 nm (178 mM-1cm-1) for human met-Hb was used to determine protein 
concentration.15 
 
5.2.5 EPR spectroscopy 
 
EPR spectra were recorded on a Bruker ESP 300 equipped with an Oxford liquid 
helium cryostat and an ITC4 temperature controller.  Samples were prepared at room 
temperature by diluting protein to a final concentration of 300 M with 50 mM buffer.  All 
buffers contained 20M DTPA (diethylenetriaminepentaacetic acid) (Aldrich) as a free iron 
chelating agent.  Samples were flash frozen by repeatedly dipping in liquid N2 over 20 
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seconds, followed by submersion and storage in liquid N2 until analysis. EPR parameters, 
where otherwise not stated, were:  = 9.058 GHz, microwave power: 20db or 2mW.  T = 25 
K. number of scans = 10, scan rate = 40 Gauss/sec.  
 
5.2.6 HPLC analysis of oxacillin solutions 
 
HPLC analysis was performed on a Waters Delta 600 HPLC equipped with a Vydac 
reverse-phase C-18 column (5 m, 4.6 mm, Model #218TP5405).  Separations were carried 
out at room temperature with a methanol/water gradient from 20% v/v to 96% v/v over 120 
minutes in the presence of 0.1 % TFA while monitoring absorbance at 220 nm.  Injections 
were 100 L.  
 
5.3 Results and discussion 
 
5.3.1 Combining buffers of opposing temperature coefficients 
 
Dr. Hee Jung Hwang previously established using our protocols that potassium 
phosphate shows a decrease in apparent pH upon cooling, while other buffers such as MOPS 
and and Tris·HCl show in increase.  We then expanded the repertoire of buffers by acquiring 
temperature versus pH data for the Good’s buffer series.16,  17 Shown in Table 5.1 is a 
summary of the investigated buffers and the associated apparent pH changes observed upon 
cooling to -180 C. 
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Table 5.1. Apparent pH change for select buffer combinations upon cooling to -180 C 
Buffer System pH at 298 K pH at plateau pH 
KPhosphate 8.0 7.3 -0.7 
KPhosphate 7.0 6.5 -0.5 
Na-Acetate 5.0 5.4 +0.4 
MOPS 6.1 7.7 +1.6 
Tris 7.0 9.2 +2.2 
BisTris 6.0 8.1 +2.1 
BisTrisPropane (BTP) 6.1 8.2 +2.1 
MES 6.0 7.4 +1.4 
HEPES 6.3 7.6 +1.3 
HEPES  7.0 8.5 +1.5 
 
To obtain the TIP buffer, the apparent pH changes of the two commonly used buffers 
(HEPES and potassium phosphate) and mixtures thereof were measured at low temperature 
via ratiometric absorption spectroscopy. All buffered solutions were brought to a constant 
ionic strength of 100 mM by addition of the appropriate amount of KCl, as calculated from 
established methods. A mixture of two pH-indicator dyes (bromcresol green (BCG) and 
bromthymol blue (BTB) was used as a probe having two band maxima in the visible 
absorption spectrum, allowing for ratiometric calibration of pH values at different 
temperatures that is not vulnerable to baseline shifts often affiliated with low temperature 
absorption spectral characterization. Optical experiments were conducted in the presence of 
glycerol as a glassing agent to maintain optical transparency at cryotemperature. As shown in 
Table 5.1, the apparent pH of HEPES buffer measuring pH 7.0 at room temperature increases 
when lowering the temperature, while the apparent pH of the phosphate buffer decreases.  
The apparent changes of pH for HEPES and phosphate buffers from 25 ˚C to -180 ˚C are 
1.52  0.20 and -0.55  0.22 units, respectively, and such pH changes are so drastic as to 
heavily influence the quantitative cryogenic investigations of pH-sensitive biomolecules. We 
subsequently monitored the effect of mixing the two buffers in different ratios and found a 
clear compensatory effect.   
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Figure 5.1. Combination of phosphate buffer with Bis Tris Propane (top) or HEPES (bottom) buffers 
results in suppression of apparent pH change upon cooling. 
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Summarized in Table 5.2 are apparent pH changes for select mixtures of two-
component buffer systems. Clearly the presence of even 40% potassium phosphate 
suppresses the pH increasing effects of Hepes and Bis Tris Propane buffers.  Remarkably, a 
combination of 60% HEPES and 40% potassium phosphate yielded a mixture showing a 
mere 0.09 unit pH change upon cooling to liquid nitrogen.  This solution was named (TIP7) 
and used for further experimental verification of pH change suppression, although other 
recipes were envisaged that would span a wide range of pH values if successfully developed 
(Table 5.3). 
 
Table 5.2. Apparent pH change for select buffer combinations upon cooling to -180 C 
Buffer System Ratio pH at 298 K pH at plateau pH 
HEPES:KPhosphate 0:100 7.0 6.5 -0.50 
HEPES:KPhosphate 25:75 7.0 6.66 -0.34 
HEPES:KPhosphate 40:60 7.0 6.74 -0.26 
HEPES:KPhosphate 50:50 7.0 6.73 -0.27 
HEPES:KPhosphate 60:40 7.0 7.09 +0.09 
HEPES:KPhosphate 100:0 7.0 8.5 +1.50 
BTP:KPhosphate 0:100 7.0 6.5 -0.50 
BTP:KPhosphate 25:75 7.0 6.71 -0.29 
BTP:KPhosphate 40:60 7.0 6.82 -0.18 
 
Table 5.3. Hypothetical Temperature-independent buffer systems over a broad range of pH 
values 
Buffer System Effective pH Range 
KPhosphate-KPhthalate 2.0-3.8 
NaTartrate-NaAcetate 3.5-5.6 
MES-KPhosphate 5.2-8.1 
NaTRIS-NaBorate 7.2-9.0 
BisTrisPropane-NaBorate 8.3-10.0 
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5.3.2 Utility of TIP buffer in antibiotic storage 
 
To explore the utility of such a TIP buffer in preserving integrity of samples stored at 
low temperature, we employed the pH-sensitive pharmaceutical drug, oxacillin; a penicillin 
analog. The instability of -lactam containing drugs in acidic or basic solution has been 
known since the discovery of penicillin by Fleming in 1929,18 and the pathways of 
degradation in aqueous solution have since been mapped out in detail.19  Inactivation of -
lactam antibiotics in acidic or basic solution has been correlated with the initial opening of 
the -lactam ring, resulting in irreversible deactivation.19 Oxacillin has been previously 
shown to be most stable in buffered aqueous solution of pH 6.0-6.5;20 a suitable range to 
evaluate the TIP7 buffer system relative to the buffers from which it was comprised.  
Solutions of oxacillin were prepared at 4 C in the presence of 50 mM HEPES, 
potassium phosphate, Bis-Tris Propane and TIP7 buffers at pH 7.0. Aliquots of each solution 
were then subject to storage in a freezer at -20 C, and the degradation of oxacillin was 
monitored quantitatively over several days via thawing and subsequent HPLC analysis. 
Control samples (light colors) were thawed only at the end of the test period, and indicate 
that the freeze/thaw process itself was not responsible for the observed degradation. All 
buffered solutions measured pH 7.00  0.05 at 25 C before and after storage.  
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Figure 5.2. Inactivation of oxacillin stored at -20 C in various 50 mM buffered solutions.  (a) HPLC 
chromatograms showing base catalyzed conversion of 100 M oxacillin (Tr 22.5 min) to its 
hydrolysis product (Tr 17.8 min) over time at -20 C in HEPES and TIP7 buffers. (b) Degradation of 
oxacillin in different buffers at low temperatures. Samples in dark blue were thawed every 48 hours 
and refrozen after analysis. Control solutions in light blue remained frozen until end of trial. Error 
bars are standard deviations of three injections from the same sample.  All HPLC separations were 
performed at 25 C while monitoring A220.  All samples measured pH 7.0 at 25 C. 
 
Shown in Figure 5.2 are HPLC chromatograms exhibiting the conversion of oxacillin 
(Tr  22.5 min) to its hydrolysis product (Tr 17.8 min) over time upon storage at -20 C the 
presence of  HEPES (Fig. 5.2.a) and TIP7 (Fig. 5.2.b) buffers. A sample of the major 
hydrolysis product at Tr = 17.8 min was collected at 4 C for each buffer and in all cases was 
identified as the -lactam hydrolysis species via electrospray mass spectrometry (ESI- (m/z) 
obs. 208.2 calc. 208.7 (M-2H+)/2).  
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Figure 5.3. Negative mode ESI-MS spectrum of hydroxlysis product, oxacilloic acid (obs. = 208.1 
calc. 208.7 (M-2H+)/2).  
 
No buffer-oxacillin adducts could be observed, implicating a water molecule as the 
incoming nucleophile. Consistent with the indicator dye experiments, increased rates of 
hydrolysis were observed for bis-tris propane and HEPES buffers, and were attributed to an 
increase in pH of the solution upon storage at -20 C. Remarkably, even after 144 hours, the 
extent of hydrolysis observed in TIP7 buffer (60:40 HEPES:potassium phosphate) is only 
7.6% of that observed in HEPES alone; with 95.6% of the oxacillin remaining intact, 
compared with 4.4% remaining in HEPES solution. No hydrolysis was observable in 
potassium phosphate buffer over the reported test period, consistent with an expected 
decrease in pH from 7.0 into the optimal stability range for this particular antibiotic.  
These results established that, under suitable conditions, a combination of buffers of 
opposing temperature coefficients can prevent -lactam ring hydrolysis as a result of 
temperature-induced pH change. 
 
5.3.3 Low-temperature spectroscopy of human hemoglobin 
 
To demonstrate the utility of the TIP buffer for conducting accurate spectroscopic 
studies of biomolecules at cryotemperatures, we measured the UV-vis absorption spectrum of 
human methemoglobin (met-Hb) at 25 ˚C and upon cooling over 30 seconds to -140 ˚C in 
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potassium phosphate, HEPES, bis-tris propane (BTP) and TIP buffers, all starting at pH 7.0 
at 25 ˚C (Fig. 3). Flash freezing experiments were employed in the case as it has been 
reported that glycerol induce spectral changes in myoglobins over time,4 and we sought to 
isolate only temperature/pH phenomena. The ferric state of human met-Hb exhibits a pH 
dependent equilibrium between high-spin normal state at low pH (Fe-OH2, with absorptions 
at 500 and 630 nm) and low-spin alkaline state at high pH (Fe-OH, with absorptions at 540 
and 575 nm), with a  pKa of 8.05 at 25 °C.21  
The met-Hb spectrum in potassium phosphate buffer at -140 °C showed most 
similarity to that at room temperature, while TIP7 buffer yielded a spectrum intermediate 
between HEPES and potassium phosphate alone. BTP was used as a positive control, as a 
large pH increase was expected upon cooling.  Clearly, more alkaline signal is observable in 
HEPES buffer than in TIP7 buffer because of its pH increase upon freezing, as is a decrease 
in alkaline signal from the room temperature spectrum in the presence of potassium 
phosphate buffer because of its pH decrease upon freezing  
 
 
Figure 5.4. (Left) Spectral changes in a solution of human hemoglobin (0. 025 mM) in 50 mM 
potassium phosphate buffer from pH 7.0 to 8.6 at 25 °C. (Right) UV-vis spectra upon flash freezing a 
solution of hemoglobin at a starting pH of 7.00 in various butters at 50 mM over 30 seconds.   Frozen 
solutions contained 20% glycerol as a glassing agent.  
 
Previous EPR studies have revealed a pH dependent equilibrium between at least 
three distinct low-spin ferric iron states in human met-Hb.22 Shown in Fig. 2a are the high-
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field (low-spin region) EPR spectra of met-Hb at 25 K at different pH values (measured at 
298 K) in potassium phosphate buffer.  
 
 
Figure 5.5. Met-Hb as an EPR probe for low temperature pH change. a, 300 M met-Hb in 50mM 
KPhosphate buffer at different pH’s measured at 298 K. b, 300 M met-Hb in 50 mM various buffers 
measuring pH 7.0 at 298 K.  Spectra were collected at 25 K. 
 
As shown in Figure 5.5 (left), the EPR spectrum of Met-Hb differs as a function of 
starting pH in 50 mM potassium phosphate buffer. From the top spectrum to the bottom 
spectrum, increasing relative concentrations of the true ‘alkaline’ Fe-OH state (LS3, gx = 
2.56, gy= 2.17, gz = 1.83) are observable, along with decreasing concentrations of two other 
low-spin states (LS1/LS2, Average gx=2.79, gy=2.26, gz=1.65), consistent with increasing 
pH.22  The two similar low-spin states present at low pH (unresolved herein) are postulated as 
histidine hemichromes that differ by a protonation event at a distant amino acid. Figure 5.5 
(right) shows the same pH dependent trend observed across the series of four buffers, all 
having measured pH 7.0 at 298 K before experimentation.  In agreement with the indicator 
dye experiments and UV-vis experiments with the same system, the distribution of the high 
pH and low pH spin states in TIP7 buffer falls between the distribution in potassium 
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phosphate and HEPES buffers alone; here in the absence of glycerol.  The spectrum in BTP 
buffer is shown as a positive control, as the largest pH change was expected for this buffer 
upon freezing. 
 
 5.4    Summary 
 
In summary, we have carried out a systematic quantification of pH changes of two 
commonly used buffers under cryotemperatures and, based on the study, we have developed 
a temperature independent pH buffer. We further demonstrate such a TIP buffer can help 
maintain integrity of pH-sensitive pharmaceutical drugs such as oxacillin when storing the 
sample under low temperature. We also demonstrate utility in pH-dependent spectroscopic 
analysis at cryotemperature, as in the visible absorbance spectrum of human methemoglobin. 
The ratiometric method to quantify pH changes and the strategy of mixing different buffers 
of opposite pH changes with temperatures to result in temperature independent pH buffers 
can be generally applied in other buffer systems at a different pH. Such buffers should find 
wide utility in cryostorage and biophysical studies of pH sensitive compounds at low 
temperature. This work was published in the RSC journal Chemical Communications in 
2008,1 and has been referenced once since its realease.23 
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